item_collection_id	collection_type_id	value	comment	clinical_item_id
1000003	1	2		49251
1000003	3	1		49251
1000003	1	2	Pericarditis imaging	61832
1000003	3	1	Pericarditis imaging	61832
1000003	1	2	Aortic imaging	45963
1000003	3	1	Aortic imaging	45963
1000003	1	2		62083
1000003	3	2		62083
1000003	1	2		45866
1000003	3	1		45866
1000003	1	2		62037
1000003	3	1		62037
1000003	1	2		48522
1000003	3	1		48522
1000003	1	2		48676
1000003	3	1		48676
1000003	1	2		45762
1000003	3	1		45762
1000003	1	2	CT calcium scoring specifically, may not be offered here	48698
1000003	3	1	CT calcium scoring specifically, may not be offered here	48698
1000003	1	2		45818
1000003	3	1		45818
1000003	1	2		45801
1000003	3	1		45801
1000003	1	2	Alternative diagnosis, PE workup	45760
1000003	3	1	Alternative diagnosis, PE workup	45760
1000003	1			45788
1000003	3	2		45788
1000003	1		Assess for exacerbating anemia	45793
1000003	3	2	Assess for exacerbating anemia	45793
1000003	1			45891
1000003	3	2		45891
1000003	1	3	Obsolete. Should not be used when have Troponin testing	45892
1000003	3	3	Do not use when have troponin testing	45892
1000003	1	2.5	Not for ACS diagnosis	45853
1000003	3	1	Not for ACS diagnosis	45853
1000003	1	2		46098
1000003	3	2		46098
1000003	1	2		45838
1000003	3	1		45838
1000003	1	2		45870
1000003	3	1		45870
1000003	1	2		45750
1000003	3	2		45750
1000003	1	2		46041
1000003	3	2		46041
1000003	1	2		45827
1000003	3	1		45827
1000003	1	2	Not routine	45900
1000003	3	1	Not routine	45900
1000003	1	2	Not routine	45864
1000003	3	1	Not routine	45864
1000003	1	2	Alternative diagnosis, PE workup	45955
1000003	3	2	Alternative diagnosis, PE workup	45955
1000003	1	2		46064
1000003	3	2		46064
1000003	1	2	Alternative diagnosis, PE workup	46185
1000003	3	2	Alternative diagnosis, PE workup	46185
1000003	1	2		45914
1000003	3	1		45914
1000003	1	2	Not routine	45921
1000003	3	1	Not routine	45921
1000003	1	2		44206
1000003	1	2		44315
1000003	3	1		44206
1000003	3	1		44315
1000003	1	2	Beware sildenafil, vardenafil, tadalafil	44256
1000003	1	2		44285
1000003	1	2		44241
1000003	3	1	Beware sildenafil, vardenafil, tadalafil	44256
1000003	3	1		44285
1000003	3	1		44241
1000003	1	2		44294
1000003	3	1		44294
1000004	1	1	Intermediate Risk	62083
1000004	3	1	Intermediate Risk	62083
1000004	1	1		45866
1000004	3	1		45866
1000004	1	1	High-risk patients	62037
1000004	3	1	High-risk patients	62037
1000004	1	2	Exclude other diagnoses	48522
1000004	3	1	Exclude other diagnoses	48522
1000004	1	2	Exclude other diagnoses	48676
1000004	3	1	Exclude other diagnoses	48676
1000004	1	2	Exclude other diagnoses	45762
1000004	3	1	Exclude other diagnoses	45762
1000004	1	1	Low risk CT calcium scoring specifically, may not be offered here	48698
1000004	3	1	Low risk CT calcium scoring specifically, may not be offered here	48698
1000004	1	2	Exclude other diagnoses	45818
1000004	3	1	Exclude other diagnoses	45818
1000004	1	2	Exclude other diagnoses	45801
1000004	3	1	Exclude other diagnoses	45801
1000004	1	2		45788
1000004	3	2		45788
1000004	1	2	Assess for exacerbating anemia	45793
1000004	3	2	Assess for exacerbating anemia	45793
1000004	1	2		45891
1000004	3	2		45891
1000004	1	3	Not for ACS diagnosis	45853
1000004	3	3	Not for ACS diagnosis	45853
1000004	1	2	Pre-req to CT Angio	46098
1000004	3	2	Pre-req to CT Angio	46098
1000004	1	2		45838
1000004	3	1		45838
1000004	1	2		45870
1000004	3	1		45870
1000004	1	1		45750
1000004	3	1		45750
1000004	1	1		46041
1000004	3	1		46041
1000004	1	1	If low O2 sat Not routine	45900
1000004	3	1	If low O2 sat Not routine	45900
1000004	1	1	If low O2 sat Not routine	45864
1000004	3	1	If low O2 sat Not routine	45864
1000004	1	2	Pre-req to CT Angio	46064
1000004	3	2	Pre-req to CT Angio	46064
1000004	1	2		45914
1000004	3	1		45914
1000004	1	1	If low O2 sat Not routine	45921
1000004	3	1	If low O2 sat Not routine	45921
1000004	1	2		44206
1000004	1	2		44315
1000004	3	1		44206
1000004	3	1		44315
1000004	1	2	Suspected ACS Beware sildenafil, vardenafil, tadalafil	44256
1000004	1	2		44285
1000004	3	1	Suspected ACS Beware sildenafil, vardenafil, tadalafil	44256
1000004	3	1		44285
1000004	1	2		44294
1000004	3	1		44294
1000005	1	2.1		49207
1000005	3	2.5		49207
1000005	1	2	Recurrent bleed after 2xEGD	49055
1000005	3	1	Recurrent bleed after 2xEGD	49055
1000005	1	1	Consult for endoscopy (EGD or Colonoscopy)	49481
1000005	3	2	Consult for endoscopy (EGD or Colonoscopy)	49481
1000005	1	2	Recurrent bleed after 2xEGD	48502
1000005	3	1	Recurrent bleed after 2xEGD	48502
1000005	1	2	High-risk EGD findings, keep in hospital, but can feed clear liquids	45784
1000005	3	1	High-risk EGD findings, keep in hospital, but can feed clear liquids	45784
1000005	1	1	Part of EGD process	45811
1000005	3	2	Part of EGD process	45811
1000005	1	1	Part of EGD process	46008
1000005	3	2	Part of EGD process	46008
1000005	1	2.1		45866
1000005	3	2.5		45866
1000005	1	1	Within 24 hours, plus also conditional repeat look if further bleeding	45969
1000005	3	1	Within 24 hours, plus also conditional repeat look if further bleeding	45969
1000005	1	2	Part of RBC transfusion	45927
1000005	3	2	Part of RBC transfusion	45927
1000005	1	2	Part of risk assessment	45788
1000005	3	2	Part of risk assessment	45788
1000005	1	2	Part of risk assessment	45793
1000005	3	2	Part of risk assessment	45793
1000005	1	2	Part of risk assessment	45891
1000005	3	2	Part of risk assessment	45891
1000005	1	2	Confirmation if negative biopsy	45948
1000005	3	1	Confirmation if negative biopsy	45948
1000005	1	2.1		45918
1000005	3	2.5		45918
1000005	1	2	Part of risk assessment	45763
1000005	3	2	Part of risk assessment	45763
1000005	1	2	Part of risk assessment	45771
1000005	3	2	Part of risk assessment	45771
1000005	1	2.1		46020
1000005	3	2.5		46020
1000005	1	2.1		45888
1000005	3	2.5		45888
1000005	1	2.1		45838
1000005	3	2.5		45838
1000005	1	2.1		45870
1000005	3	2.5		45870
1000005	1	2	Part of transfusion	45945
1000005	3	2	Part of transfusion	45945
1000005	3	2	Endoscopy pre-medication	44233
1000005	1	1	Endoscopy pre-medication	44233
1000005	1	1	Part of hemodynamic assessment	45868
1000005	3	2.5	Part of hemodynamic assessment	45868
1000005	1	2.5		62039
1000005	3	1		62039
1000005	1	2	Target Hgb>7 or higher if comorbidities	61975
1000005	3	1	Target Hgb>7 or higher if comorbidities	61975
1000005	1	2	Bleeding ulcer H Pylori biopsy presumably here	46192
1000005	3	2	Bleeding ulcer H Pylori biopsy presumably here	46192
1000005	1	2.1		45955
1000005	3	2.5		45955
1000005	1	2.1		45914
1000005	3	2.5		45914
1000005	1	2	Continue secondary prevention ASAP usually within 3 days	47146
1000005	3	1	Continue secondary prevention ASAP usually within 3 days	47146
1000005	3	1		44592
1000005	1	2		44592
1000005	1	1	Endoscopic stigmata of hemorrhage or no EGD	44219
1000005	1	1	Low-risk EGD findings then long-term conditionally	44236
1000005	3	1	Endoscopic stigmata of hemorrhage or no EGD	44219
1000005	3	1	Low-risk EGD findings then long-term conditionally	44236
1000005	1	1	Resucitation	44198
1000005	3	2	Resucitation	44198
1000006	1	1	Consult for endoscopy (EGD or Colonoscopy)	49481
1000006	3	2	Consult for endoscopy (EGD or Colonoscopy)	49481
1000006	1	1	Lower GI Bleed	50005
1000006	3	1	Lower GI Bleed	50005
1000006	1	1	Lower GI Bleed	46072
1000006	3	1	Lower GI Bleed	46072
1000006	1	1	Lower GI Bleed	45858
1000006	3	1	Lower GI Bleed	45858
1000006	1	1	Lower GI Bleed	45852
1000006	3	1	Lower GI Bleed	45852
1000006	1	1		51281
1000006	3	2.5		51281
1000006	1	1	Part of Colonoscopy process (Bowel Prep Ingredient)	46427
1000006	3	2	Part of Colonoscopy process (Bowel Prep Ingredient)	46427
1000007	3	2.5	Coagulopathy	35692
1000007	3	2.5	Coagulopathy	35693
1000007	3	2.5	Coagulopathy	35672
1000007	3	2.5	Coagulopathy	35673
1000007	3	2.5	Coagulopathy	35680
1000007	3	2.5	Coagulopathy	35700
1000007	3	2.5	Coagulopathy	35699
1000007	3	2.5		51586
1000007	1	1		51586
1000007	1	2.1		49207
1000007	3	2.5		49207
1000007	1	1	Unstable after EGD, IR unavailable	49055
1000007	3	1	Unstable after EGD, IR unavailable	49055
1000007	1	1	Consult for endoscopy (EGD or Colonoscopy)	49481
1000007	3	2	Consult for endoscopy (EGD or Colonoscopy)	49481
1000007	1	1	Unstable after EGD	48502
1000007	3	1	Unstable after EGD	48502
1000007	1	2.1		45784
1000007	3	1		45784
1000007	1	1	Part of EGD process	45811
1000007	3	2	Part of EGD process	45811
1000007	1	1	Part of EGD process	46008
1000007	3	2	Part of EGD process	46008
1000007	1	2.1		45866
1000007	3	2.5		45866
1000007	1	1		45969
1000007	3	1		45969
1000007	1	2	Part of FFP transfusion	45872
1000007	1	2	Part of Plt transfusion	45875
1000007	1	2	Part of RBC transfusion	45927
1000007	3	2	Part of RBC transfusion	45927
1000007	1	1	Part of risk assessment	45788
1000007	3	2	Part of risk assessment	45788
1000007	1	1	Part of risk assessment	45793
1000007	3	2	Part of risk assessment	45793
1000007	1	2	Part of FFP transfuse assessment	46286
1000007	1	1	Part of risk assessment	45891
1000007	3	2	Part of risk assessment	45891
1000007	1	2.1		45948
1000007	3	1		45948
1000007	1	2.1		45918
1000007	3	2.5		45918
1000007	1	1	Part of risk assessment	45763
1000007	3	2	Part of risk assessment	45763
1000007	1	1	Part of risk assessment	45771
1000007	3	2	Part of risk assessment	45771
1000007	1	2.1		46020
1000007	3	2.5		46020
1000007	1	2.1		45888
1000007	3	2.5		45888
1000007	1	2.1		45838
1000007	3	2.5		45838
1000007	1	2	Part of FFP transfuse assessment	45759
1000007	1	2	Part of FFP transfuse assessment	45770
1000007	1	2.1		45870
1000007	3	2.5		45870
1000007	1	2	Part of transfusion	45945
1000007	3	2	Part of transfusion	45945
1000007	3	2	Endoscopy pre-medication	44233
1000007	1	1	Endoscopy pre-medication	44233
1000007	1	2.1		45868
1000007	3	2.5	Part of hemodynamic assessment	45868
1000007	1	2.1		62039
1000007	3	1		62039
1000007	1	2	Massive Bleeding, coagulopathy	61993
1000007	1	2	Massive Bleeding, Plt<50	61976
1000007	1	2	Massive Bleeding, Clinical Assessment	61975
1000007	3	1	Massive Bleeding, Clinical Assessment	61975
1000007	1	2.1		46192
1000007	3	2	H Pylori biopsy presumably here	46192
1000007	1	2.1		45955
1000007	3	2.5		45955
1000007	1	2.1		45914
1000007	3	2.5		45914
1000007	1	1	Continue secondary prevention and hemostasis achieved	47146
1000007	3	1	Continue secondary prevention and hemostasis achieved	47146
1000007	3	2		35733
1000007	1	1		35733
1000007	1	1	Variceal Prophylactic Antibiotics	44249
1000007	1	1	Variceal Prophylactic Antibiotics	44262
1000007	3	2.5	Variceal Prophylactic Antibiotics	44249
1000007	3	2.5	Variceal Prophylactic Antibiotics	44262
1000007	3	1		44592
1000007	1	2		44592
1000007	1	2.1		44236
1000007	1	2	Non-variceal	44219
1000007	3	1	Non-variceal	44219
1000007	3	1		44236
1000007	1	2.5	Unless all other methods fail	46722
1000007	3	3	Unless all other methods fail	46722
1000007	1	2	Warfarin, bleeding protocol	44001
1000007	3	2	Warfarin, bleeding protocol	44001
1000007	3	2	Warfarin, bleeding protocol	44001
1000007	1	2.1		44198
1000007	3	2	Resucitation	44198
1000008	3	2.5		51586
1000008	1	1		51586
1000008	1	2.1		49207
1000008	3	2.5		49207
1000008	1	1	Consult for endoscopy (EGD or Colonoscopy)	49481
1000008	3	2	Consult for endoscopy (EGD or Colonoscopy)	49481
1000008	1	1	Part of EGD process	45811
1000008	3	2	Part of EGD process	45811
1000008	1	1	Part of EGD process	46008
1000008	3	2	Part of EGD process	46008
1000008	1	2.1		45866
1000008	3	2.5		45866
1000008	1	1		45969
1000008	3	1		45969
1000008	1	2	Part of RBC transfusion	45927
1000008	3	2	Part of RBC transfusion	45927
1000008	1	2.1		45918
1000008	3	2.5		45918
1000008	1	2.1		46020
1000008	3	2.5		46020
1000008	1	2.1		45888
1000008	3	2.5		45888
1000008	1	2.1		45838
1000008	3	2.5		45838
1000008	1	2.1		45870
1000008	3	2.5		45870
1000008	1	2	Part of transfusion	45945
1000008	3	2	Part of transfusion	45945
1000008	3	2	Endoscopy pre-medication	44233
1000008	1	1	Endoscopy pre-medication	44233
1000008	1	2	Part of hemodynamic assessment	45868
1000008	3	2.5	Part of hemodynamic assessment	45868
1000008	1	2		61975
1000008	3	1		61975
1000008	1	2.1		45955
1000008	3	2.5		45955
1000008	1	2.1		45914
1000008	3	2.5		45914
1000008	1	2.5	Intubation to avoid aspirating if massive bleed	45832
1000008	3	1	Intubation to avoid aspirating if massive bleed	45832
1000008	1	2.1		47146
1000008	3	1		47146
1000008	3	2		35733
1000008	1	1		35733
1000008	1	1	Prophylactic Antibiotics	44262
1000008	3	2	Prophylactic Antibiotics	44262
1000008	1	2		43996
1000008	3	1		43996
1000008	1	2	Resucitation	44198
1000008	3	2	Resucitation	44198
1000012	1	1	8.9 Transitions of Care	49251
1000012	2	2	8.9 Transitions of Care	49251
1000012	3	2.5	8.9 Transitions of Care	49251
1000012	1	1	8.9 Transitions of Care	65695
1000012	2	2	8.9 Transitions of Care	65695
1000012	3	2.5	8.9 Transitions of Care	65695
1000012	1	2	7.3.1.3 Sodium Restriction	61989
1000012	2	3	7.3.1.3 Sodium Restriction	61989
1000012	3	2	7.3.1.3 Sodium Restriction	61989
1000012	1	2	7.3.1.3 Sodium Restriction	45824
1000012	2	3	7.3.1.3 Sodium Restriction	45824
1000012	3	2	7.3.1.3 Sodium Restriction	45824
1000012	1	1	6.4 Non-Invasive Imaging	61832
1000012	2	3	6.4 Non-Invasive Imaging	61832
1000012	3	1	6.4 Non-Invasive Imaging	61832
1000012	1	1	8.2 Precipitating Causes: ACS	45866
1000012	1	1	6.2 Initial Diagnostics	45866
1000012	2	3	8.2 Precipitating Causes: ACS	45866
1000012	2	3	6.2 Initial Diagnostics	45866
1000012	3	1	8.2 Precipitating Causes: ACS	45866
1000012	3	1	6.2 Initial Diagnostics	45866
1000012	1	1	6.4 Non-Invasive Imaging	45818
1000012	2	3	6.4 Non-Invasive Imaging	45818
1000012	3	1	6.4 Non-Invasive Imaging	45818
1000012	1	1	6.4 Non-Invasive Imaging	45801
1000012	2	3	6.4 Non-Invasive Imaging	45801
1000012	3	1	6.4 Non-Invasive Imaging	45801
1000012	1	1	6.2 Initial Diagnostics	45788
1000012	2	3	6.2 Initial Diagnostics	45788
1000012	3	1	6.2 Initial Diagnostics	45788
1000012	1	1	6.2 Initial Diagnostics	45793
1000012	2	3	6.2 Initial Diagnostics	45793
1000012	3	1	6.2 Initial Diagnostics	45793
1000012	1	1	6.2 Initial Diagnostics	45910
1000012	2	3	6.2 Initial Diagnostics	45910
1000012	3	1	6.2 Initial Diagnostics	45910
1000012	1	1	6.2 Initial Diagnostics	61837
1000012	2	3	6.2 Initial Diagnostics	61837
1000012	3	1	6.2 Initial Diagnostics	61837
1000012	1	1	8.4 Diuretic Monitoring	45763
1000012	1	1	6.2 Initial Diagnostics	45763
1000012	2	3	8.4 Diuretic Monitoring	45763
1000012	2	3	6.2 Initial Diagnostics	45763
1000012	3	2	8.4 Diuretic Monitoring	45763
1000012	3	2	6.2 Initial Diagnostics	45763
1000012	1	1	8.4 Diuretic Monitoring	45771
1000012	1	1	6.2 Initial Diagnostics	45771
1000012	2	3	8.4 Diuretic Monitoring	45771
1000012	2	3	6.2 Initial Diagnostics	45771
1000012	3	2	8.4 Diuretic Monitoring	45771
1000012	3	2	6.2 Initial Diagnostics	45771
1000012	1	1	8.4 Diuretic Monitoring	45806
1000012	2	3	8.4 Diuretic Monitoring	45806
1000012	3	2	8.4 Diuretic Monitoring	45806
1000012	1	1	6.3 Initial Diagnostic Biomarker	45853
1000012	2	1	6.3 Initial Diagnostic Biomarker	45853
1000012	3	1	6.3 Initial Diagnostic Biomarker	45853
1000012	1	1	8.2 Precipitating Causes: ACS	45838
1000012	2	3	8.2 Precipitating Causes: ACS	45838
1000012	3	1	8.2 Precipitating Causes: ACS	45838
1000012	1	1	8.2 Precipitating Causes: ACS	45870
1000012	2	3	8.2 Precipitating Causes: ACS	45870
1000012	3	1	8.2 Precipitating Causes: ACS	45870
1000012	1	1	6.2 Initial Diagnostics	45772
1000012	2	3	6.2 Initial Diagnostics	45772
1000012	3	1	6.2 Initial Diagnostics	45772
1000012	1	1	6.2 Initial Diagnostics	45751
1000012	2	3	6.2 Initial Diagnostics	45751
1000012	3	1	6.2 Initial Diagnostics	45751
1000012	1	1	8.4 Diuretic Monitoring	45755
1000012	2	2	8.4 Diuretic Monitoring	45755
1000012	3	2	8.4 Diuretic Monitoring	45755
1000012	1	1	8.4 Diuretic Monitoring	45766
1000012	2	2	8.4 Diuretic Monitoring	45766
1000012	3	2	8.4 Diuretic Monitoring	45766
1000012	1	2.5	8.5 Ultrafiltration	49201
1000012	1	2	8.5 Ultrafiltration	49201
1000012	3	1	8.5 Ultrafiltration	49201
1000012	1	1	8.2 Precipitating Causes: ACS	45914
1000012	2	3	8.2 Precipitating Causes: ACS	45914
1000012	3	1	8.2 Precipitating Causes: ACS	45914
1000012	1	3	7.3.2.9 Harmful drugs	44296
1000012	2	2	7.3.2.9 Harmful drugs	44296
1000012	3	3	7.3.2.9 Harmful drugs	44296
1000012	1	1	8.3 Guideline Directed Medical Therapy	45035
1000012	2	2	8.3 Guideline Directed Medical Therapy	45035
1000012	3	2.5	8.3 Guideline Directed Medical Therapy	45035
1000012	1	2.5	8.6 Parenteral Therapy for Dyspnea Relief	44686
1000012	2	1	8.6 Parenteral Therapy for Dyspnea Relief	44686
1000012	3	1	8.6 Parenteral Therapy for Dyspnea Relief	44686
1000012	1	1	8.3 Guideline Directed Medical Therapy	44340
1000012	2	2	8.3 Guideline Directed Medical Therapy	44340
1000012	3	2	8.3 Guideline Directed Medical Therapy	44340
1000012	1	2	8.4 Diuretic Enhancement	44309
1000012	2	2	8.4 Diuretic Enhancement	44309
1000012	3	2	8.4 Diuretic Enhancement	44309
1000012	1	1	8.3 Guideline Directed Medical Therapy	44357
1000012	2	2	8.3 Guideline Directed Medical Therapy	44357
1000012	3	2	8.3 Guideline Directed Medical Therapy	44357
1000012	1	3	7.3.2.9 Harmful drugs	44428
1000012	2	2	7.3.2.9 Harmful drugs	44428
1000012	3	3	7.3.2.9 Harmful drugs	44428
1000012	1	2	7.3.2.7 Digoxin	44389
1000012	2	2	7.3.2.7 Digoxin	44389
1000012	3	1	7.3.2.7 Digoxin	44389
1000012	1	3	7.3.2.9 Harmful drugs	44393
1000012	2	2	7.3.2.9 Harmful drugs	44393
1000012	3	3	7.3.2.9 Harmful drugs	44393
1000012	1	2.5	8.8 Vasopressin Antagonist	46614
1000012	2	2	8.8 Vasopressin Antagonist	46614
1000012	3	2	8.8 Vasopressin Antagonist	46614
1000012	1	3	7.3.2.9 Harmful drugs	44301
1000012	2	2	7.3.2.9 Harmful drugs	44301
1000012	3	3	7.3.2.9 Harmful drugs	44301
1000012	1	2.5	7.4.4 Inotropic Support	44251
1000012	2	2	7.4.4 Inotropic Support	44251
1000012	3	2.5	7.4.4 Inotropic Support	44251
1000012	1	2.5	8.4 Diuretic Enhancement	44323
1000012	1	2.5	7.4.4 Inotropic Support	44323
1000012	2	2	8.4 Diuretic Enhancement	44323
1000012	2	2	7.4.4 Inotropic Support	44323
1000012	3	1	8.4 Diuretic Enhancement	44323
1000012	3	1	7.4.4 Inotropic Support	44323
1000012	1	1	8.3 Guideline Directed Medical Therapy	45190
1000012	2	2	8.3 Guideline Directed Medical Therapy	45190
1000012	3	2.5	8.3 Guideline Directed Medical Therapy	45190
1000012	1	1	8.4 Diuretics	44004
1000012	2	2	8.4 Diuretics	44004
1000012	3	2	8.4 Diuretics	44004
1000012	1	2.5	8.6 Parenteral Therapy for Dyspnea Relief	44241
1000012	2	1	8.6 Parenteral Therapy for Dyspnea Relief	44241
1000012	3	1	8.6 Parenteral Therapy for Dyspnea Relief	44241
1000012	1	1	8.3 Guideline Directed Medical Therapy	44374
1000012	2	2	8.3 Guideline Directed Medical Therapy	44374
1000012	3	2	8.3 Guideline Directed Medical Therapy	44374
1000012	1	1	8.7 Venous Thromboembolism Prophylaxis	44222
1000012	2	2	8.7 Venous Thromboembolism Prophylaxis	44222
1000012	3	2	8.7 Venous Thromboembolism Prophylaxis	44222
1000012	1	2.5	7.4.4 Inotropic Support	45427
1000012	2	2	7.4.4 Inotropic Support	45427
1000012	3	1	7.4.4 Inotropic Support	45427
1000012	1	2	7.3.2.6 Isodril + Hydralazine	44412
1000012	2	2	7.3.2.6 Isodril + Hydralazine	44412
1000012	3	1	7.3.2.6 Isodril + Hydralazine	44412
1000012	1	3	7.3.2.9 Harmful drugs	44271
1000012	2	2	7.3.2.9 Harmful drugs	44271
1000012	3	3	7.3.2.9 Harmful drugs	44271
1000012	1	2	7.3.2.6 Isodril + Hydralazine	44367
1000012	2	2	7.3.2.6 Isodril + Hydralazine	44367
1000012	3	1	7.3.2.6 Isodril + Hydralazine	44367
1000012	1	1	8.7 Venous Thromboembolism Prophylaxis	44250
1000012	2	2	8.7 Venous Thromboembolism Prophylaxis	44250
1000012	3	2	8.7 Venous Thromboembolism Prophylaxis	44250
1000012	1	1	8.3 Guideline Directed Medical Therapy	44005
1000012	2	2	8.3 Guideline Directed Medical Therapy	44005
1000012	3	2	8.3 Guideline Directed Medical Therapy	44005
1000012	1	1	8.3 Guideline Directed Medical Therapy	44347
1000012	2	2	8.3 Guideline Directed Medical Therapy	44347
1000012	3	2.5	8.3 Guideline Directed Medical Therapy	44347
1000012	1	3	7.3.2.9 Harmful drugs	44341
1000012	2	2	7.3.2.9 Harmful drugs	44341
1000012	3	3	7.3.2.9 Harmful drugs	44341
1000012	1	2.5	8.6 Parenteral Therapy for Dyspnea Relief	35133
1000012	2	1	8.6 Parenteral Therapy for Dyspnea Relief	35133
1000012	3	1	8.6 Parenteral Therapy for Dyspnea Relief	35133
1000012	1	1	8.3 Guideline Directed Medical Therapy	44430
1000012	2	2	8.3 Guideline Directed Medical Therapy	44430
1000012	3	2	8.3 Guideline Directed Medical Therapy	44430
1000012	1	1	7.3.4 Device Therapy - ICD	
1000012	1	1	7.3.4 Device Therapy - CRT	
1000012	2	1	7.3.4 Device Therapy - ICD	
1000012	2	1	7.3.4 Device Therapy - CRT	
1000012	3	1	7.3.4 Device Therapy - ICD	
1000012	3	1	7.3.4 Device Therapy - CRT	
1000012	3	1	7.4.3 Water Restriction	
1000012	3	2	7.4.3 Water Restriction	
1000012	3	3	7.4.3 Water Restriction	
1000011	1	2.1		49251
1000011	3	2	1.1.2 - Specialist team input	49251
1000011	1	2.1		65695
1000011	3	2	1.1.2 - Specialist team input	65695
1000011	1	2.1		61832
1000011	3	1	1.2.3 - Echo follow-up BNP	61832
1000011	1	2.1		45866
1000011	3	1	1.2.1 - Standard Investigation	45866
1000011	1	2.1		45818
1000011	3	1	1.2.1 - Standard Investigation	45818
1000011	1	2.1		45801
1000011	3	1	1.2.1 - Standard Investigation	45801
1000011	1	2.1		45788
1000011	3	2	1.2.1 - Standard Investigation	45788
1000011	1	2.1		45793
1000011	3	2	1.2.1 - Standard Investigation	45793
1000011	1	2.1		45763
1000011	3	2	1.2.1 - Standard Investigation	45763
1000011	1	2.1		45771
1000011	3	2	1.2.1 - Standard Investigation	45771
1000011	1	2.1		45806
1000011	3	2	1.2.1 - Standard Investigation	45806
1000011	1	2.1		45853
1000011	3	1	1.2.2 - Rule out measurement	45853
1000011	1	2.1		45838
1000011	3	2	1.2.1 - Standard Investigation	45838
1000011	1	2.1		45870
1000011	3	2	1.2.1 - Standard Investigation	45870
1000011	1	2.1		45755
1000011	3	1	1.3.5 - Monitor while on diuretics	45755
1000011	1	2.1		45766
1000011	3	1	1.3.5 - Monitor while on diuretics	45766
1000011	1	2.1		46058
1000011	3	3	1.2.5 - Do NOT routinely use PA Catheter	46058
1000011	1	2.1		49201
1000011	3	3	1.4.4 - No routine ultrafiltration unless confirmed diuretic resistance	49201
1000011	1	2.1		45914
1000011	3	2	1.2.1 - Standard Investigation	45914
1000011	1	2.1		46030
1000011	3	1	1.4.1 vs. 1.4.2 - NIPPV not routine but use if severe dyspnea. Does not really apply to non-CCU/ICU patients?	46030
1000011	1	2.1		45035
1000011	3	2.5	1.5.4 - ACE/ARB/Aldo	45035
1000011	1	2.1		44340
1000011	3	2	1.5.2 - Beta blockers	44340
1000011	1	2.1		44357
1000011	3	2	1.5.4 - ACE/ARB/Aldo	44357
1000011	1	2.1		44319
1000011	3	3	1.3.2 - Do NOT routinely use opioids	44319
1000011	1	2.1		44251
1000011	3	2.5	1.3.11 vs 1.3.10 - Not routine, but consider inotropes for reversible cardiogenic shock	44251
1000011	1	2.1		45190
1000011	3	2.5	1.5.4 - ACE/ARB/Aldo	45190
1000011	1	2.1		44297
1000011	3	3	1.3.2 - Do NOT routinely use opioids	44297
1000011	1	2.1		44004
1000011	3	1	1.3.3 - Intravenous diuretics	44004
1000011	1	2.1		44241
1000011	1	2.1		44256
1000011	1	2.1		44285
1000011	3	3	1.3.7 vs. 1.3.8 - Do NOT routinely use nitrates, but monitor in ICU if IV use in select scenarios	44241
1000011	3	3	1.3.7 vs. 1.3.8 - Do NOT routinely use nitrates, but monitor in ICU if IV use in select scenarios	44256
1000011	3	3	1.3.7 vs. 1.3.8 - Do NOT routinely use nitrates, but monitor in ICU if IV use in select scenarios	44285
1000011	1	2.1		44374
1000011	3	2	1.5.4 - ACE/ARB/Aldo	44374
1000011	1	2.1		44242
1000011	3	3	1.3.7 vs. 1.3.8 - Do NOT routinely use nitrates, but monitor in ICU if IV use in select scenarios	44242
1000011	1	2.1		44367
1000011	3	3	1.3.7 vs. 1.3.8 - Do NOT routinely use nitrates, but monitor in ICU if IV use in select scenarios	44367
1000011	1	2.1		44005
1000011	3	2	1.5.2 - Beta blockers	44005
1000011	1	2.1		44347
1000011	3	2.5	1.5.4 - ACE/ARB/Aldo	44347
1000011	1	2.1		44294
1000011	3	3	1.3.2 - Do NOT routinely use opioids	44294
1000011	1	2.1		35133
1000011	3	3	1.3.9 - Do NOT use nitroprusside	35133
1000011	1	2.1		44023
1000011	3	3	1.3.2 - Do NOT routinely use opioids	44023
1000011	1	2.1		44430
1000011	3	2	1.5.4 - ACE/ARB/Aldo	44430
1000009	1	2	Implied for admission	49207
1000009	3	2	Implied for admission	49207
1000009	1	2		45818
1000009	3	1		45818
1000009	1	2		45801
1000009	3	1		45801
1000009	1	1		45760
1000009	3	1		45760
1000009	1	2		45752
1000009	3	1		45752
1000009	1	2	May omit if low severity disease	45901
1000009	3	1	May omit if low severity disease	45901
1000009	1	1		45788
1000009	3	1		45788
1000009	1	1		45793
1000009	3	1		45793
1000009	1	1		46044
1000009	3	1	9 General Investigations on Admit	46044
1000009	1	2		62023
1000009	1	1		46006
1000009	3	1		46006
1000009	1	2		45910
1000009	3	1		45910
1000009	1	2		49478
1000009	3	1		49478
1000009	1	2		45835
1000009	3	1		45835
1000009	1	1		45763
1000009	3	2		45763
1000009	1	2		45771
1000009	3	2		45771
1000009	1	1	Use if moderate severity disease and no prior antibiotics	46179
1000009	3	1	Use if moderate severity disease and no prior antibiotics	46179
1000009	1	1	Use if moderate severity disease and no prior antibiotics	48544
1000009	3	1	Use if moderate severity disease and no prior antibiotics	48544
1000009	3	2		44237
1000009	1	2		44237
1000009	3	2		44391
1000009	1	2		44391
1000009	3	2		44252
1000009	1	2		44252
1000009	1	1		45750
1000009	3	2		45750
1000009	1	1		46041
1000009	3	2		46041
1000009	1	2		45900
1000009	3	1		45900
1000009	1	2		45864
1000009	3	1		45864
1000009	1	2		45955
1000009	3	2		45955
1000009	1	1		46185
1000009	3	1	9 General Investigation - Arterial Blood Gas	46185
1000009	1	2	67-69 Need not be routine, but offer if difficulty expectorating	50116
1000009	3	2.5	67-69 Need not be routine, but offer if difficulty expectorating	50116
1000009	1	2	67-69 Need not be routine, but offer if difficulty expectorating	49144
1000009	3	2.5	67-69 Need not be routine, but offer if difficulty expectorating	49144
1000009	1	1		46336
1000009	3	2		46336
1000009	1	2		45921
1000009	3	1		45921
1000009	1	2		46445
1000009	1	2		46335
1000009	3	1		46445
1000009	3	1		46335
1000009	1	2		35849
1000009	1	2		44388
1000009	3	2		35849
1000009	3	2		44388
1000009	1	2		35733
1000009	1	2		45060
1000009	3	1		35733
1000009	3	1		45060
1000009	1	2		46261
1000009	1	2		44626
1000009	3	1		46261
1000009	3	1		44626
1000009	1	1		44222
1000009	3	2		44222
1000009	1	3	Not routine	44230
1000009	3	3	Not routine	44230
1000009	1	1		44250
1000009	3	2		44250
1000009	1	3	Not routine	45225
1000009	3	3	Not routine	45225
1000009	1	2		46468
1000009	3	1		46468
1000009	1	2		44299
1000009	1	2		44324
1000009	3	1		44299
1000009	3	1		44324
1000009	1	2		44262
1000009	3	1	High Severity (Table) - Empiric Pseudomonas coverage?	44262
1000010	1	1		45818
1000010	3	1		45818
1000010	1	1		45801
1000010	3	1		45801
1000010	1	2	Suspect viral source	49054
1000010	3	1	Suspect viral source	49054
1000010	1	2	Diagnostic tests may not help that much routinely, but may still help individual cases and offer epidemiologic information	45752
1000010	3	1	Diagnostic tests may not help that much routinely, but may still help individual cases and offer epidemiologic information	45752
1000010	1	2		45901
1000010	3	1		45901
1000010	1	2	Check adrenal insufficiency if in shock	45978
1000010	3	2	Check adrenal insufficiency if in shock	45978
1000010	1	2		62023
1000010	3	2		62023
1000010	1	2		46006
1000010	3	1		46006
1000010	1	2		49478
1000010	3	2		49478
1000010	1	2		45835
1000010	3	1		45835
1000010	1	2		46179
1000010	3	1		46179
1000010	1	2.1		48544
1000010	3	1		48544
1000010	1	2		45972
1000010	3	2		45972
1000010	3	2		44237
1000010	1	2		44237
1000010	3	2		44391
1000010	1	2		44391
1000010	3	2		44252
1000010	1	2		44252
1000010	1	2	Trial before need intubation	46030
1000010	3	1	Trial before need intubation. Does not really apply to non-ICU patients	46030
1000010	1	2		46336
1000010	3	2		46336
1000010	1	2	MRSA	43997
1000010	3	1	MRSA	43997
1000010	1	2	Penicillin allergy	44678
1000010	3	1	Penicillin allergy	44678
1000010	1	1		46445
1000010	1	1		46335
1000010	3	1		46445
1000010	3	1		46335
1000010	1	1		35849
1000010	1	1		44388
1000010	3	1		35849
1000010	3	1		44388
1000010	3	1		36210
1000010	1	2		36210
1000010	1	1		35733
1000010	1	1		45060
1000010	3	1		35733
1000010	3	1		45060
1000010	1	2	Pseudomonas	44262
1000010	3	1	Pseudomonas	44262
1000010	1	1	Influenza A	45480
1000010	3	1	Influenza A	45480
1000010	3	1		44008
1000010	1	2		44008
1000010	3	1		43998
1000010	1	2		43998
1000010	1	2		46261
1000010	1	2		44626
1000010	3	1		46261
1000010	3	1		44626
1000010	1	1		46468
1000010	3	1		46468
1000010	1	1		44299
1000010	1	1		44324
1000010	3	1		44299
1000010	3	1		44324
1000010	1	2	Fluid resuscitation implied	44198
1000010	3	2	Fluid resuscitation implied	44198
1000001	1	1		50202
1000001	2	3		50202
1000001	3	1		50202
1000001	1	1		49678
1000001	2	2		49678
1000001	3	1		49678
1000001	1	1		61832
1000001	2	2		61832
1000001	3	1		61832
1000001	1	1		62176
1000001	2	2		62176
1000001	3	1		62176
1000001	1	1		52590
1000001	2	3		52590
1000001	3	1		52590
1000001	1	1		62057
1000001	2	2		62057
1000001	3	1		62057
1000001	1	1		45866
1000001	2	2		45866
1000001	3	1		45866
1000001	1	3		45983
1000001	2	2		45983
1000001	3	3		45983
1000001	1	3		48524
1000001	2	2		48524
1000001	3	3		48524
1000001	1	3		46039
1000001	2	2		46039
1000001	3	3		46039
1000001	1	3		46065
1000001	2	2		46065
1000001	3	3		46065
1000001	1	3		48773
1000001	2	2		48773
1000001	3	3		48773
1000001	1	2.1	Table 11 - Important Co-morbidities	45788
1000001	3	2	Table 11 - Important Co-morbidities	45788
1000001	1	2.1	Table 11 - Important Co-morbidities	45793
1000001	3	2	Table 11 - Important Co-morbidities	45793
1000001	1	2.1	Table 11 - Important Co-morbidities	45763
1000001	3	2	Table 11 - Important Co-morbidities	45763
1000001	1	2.1	Table 11 - Important Co-morbidities	45771
1000001	3	2	Table 11 - Important Co-morbidities	45771
1000001	1	2.1	3.4.1 Necessitates evaluation of ischemia?	45838
1000001	3	2	3.4.1 Necessitates evaluation of ischemia?	45838
1000001	1	2.1	3.4.1 Necessitates evaluation of ischemia?	45870
1000001	3	2	3.4.1 Necessitates evaluation of ischemia?	45870
1000001	1	3		46200
1000001	2	2		46200
1000001	3	3		46200
1000001	1	1		45868
1000001	2	2		45868
1000001	3	1		45868
1000001	1	1		45827
1000001	2	3		45827
1000001	3	1		45827
1000001	1	2.1	3.4.1 Necessitates evaluation of ischemia?	45914
1000001	3	2	3.4.1 Necessitates evaluation of ischemia?	45914
1000001	1	3	Adenosine (ATP) Test?	46605
1000001	2	2	Adenosine (ATP) Test?	46605
1000001	3	3	Adenosine (ATP) Test?	46605
1000001	1	2		46462
1000001	2	3		46462
1000001	3	1		46462
1000001	1	3		44005
1000001	2	1		44005
1000001	3	3		44005
1000001	1	2		44756
1000001	2	2		44756
1000001	3	1		44756
1000001	1	3		62214
1000001	2	2		62214
1000001	3	3		62214
1000001	1	1	Carotid Sinus Massage	
1000001	1	2	Electrophysiologic Testing	
1000001	1	1	Tilt Table	
1000001	2	2	Carotid Sinus Massage	
1000001	2	2	Electrophysiologic Testing	
1000001	2	3	Tilt Table	
1000001	3	1	Carotid Sinus Massage	
1000001	3	1	Electrophysiologic Testing	
1000001	3	1	Tilt Table	
1000002	1	2	Mixed recs depending on headache	63811
1000002	3	2		63811
1000002	1	2.1		49251
1000002	3	2	Admission	49251
1000002	1	2.1		49207
1000002	3	2	Admission	49207
1000002	1	2.1		61832
1000002	3	1		61832
1000002	1	2.1		62176
1000002	3	1		62176
1000002	1	2.1		45866
1000002	3	1		45866
1000002	1	2	Mixed recs depending on headache	45983
1000002	3	1		45983
1000002	1	2	Mixed recs depending on headache	48524
1000002	3	2		48524
1000002	1	2.1		48676
1000002	3	2	If suspect PE	48676
1000002	1	2.1		45762
1000002	3	2	If suspect PE	45762
1000002	1	2	Mixed recs depending on headache	50989
1000002	3	2		50989
1000002	1	2	Mixed recs depending on headache	46039
1000002	3	1		46039
1000002	1	2	Mixed recs depending on headache	46065
1000002	3	1		46065
1000002	1	2.1		45788
1000002	3	2		45788
1000002	1	2.1		45793
1000002	3	2		45793
1000002	1	2.1		45763
1000002	3	2		45763
1000002	1	2.1		45771
1000002	3	2		45771
1000002	1	2.5		45853
1000002	3	1		45853
1000002	1	2.5		45838
1000002	3	1		45838
1000002	1	2.5		45870
1000002	3	1		45870
1000002	1	2		46200
1000002	3	1		46200
1000002	1	2.1		45827
1000002	3	1		45827
1000002	1	2.5		45914
1000002	3	1		45914
1000002	1	2.1		48561
1000002	3	1		48561
1000013	1	2.1		45955
1000013	3	2	Headache, Hypoventilation - CO-Hgb	45955
1000013	1	2.1		45983
1000013	3	1	Trauma, Headache, Immunocompromised, Anticoagulants, Unarousable	45983
1000013	1	2.1		49173
1000013	3	1	Headache	49173
1000013	1	1		45900
1000013	3	2	CO Poisoning, Unarousable	45900
1000013	1	1		45864
1000013	3	2	CO Poisoning, Unarousable	45864
1000013	1	1		45921
1000013	3	2.5	CO Poisoning, Unarousable	45921
1000013	1	2.1		63811
1000013	3	1	Immunocompromised, Unarousable - Septic Workup - LP	63811
1000013	1	2.1		49083
1000013	1	2.1		48880
1000013	1	2.1		48577
1000013	1	2.1		49020
1000013	3	2	Immunocompromised, Unarousable - Septic Workup - LP	49083
1000013	3	2	Immunocompromised, Unarousable - Septic Workup - LP	48880
1000013	3	2	Immunocompromised, Unarousable - Septic Workup - LP	48577
1000013	3	2	Immunocompromised, Unarousable - Septic Workup - LP	49020
1000013	1	2.1		46039
1000013	1	2.1		46065
1000013	1	2.1		45889
1000013	3	2	Immunocompromised	46039
1000013	3	1	Immunocompromised	46065
1000013	3	2	Immunocompromised	45889
1000013	1	2.1		46200
1000013	3	1	Seizures, Unarousable	46200
1000013	1	2.1		49334
1000013	3	2	Seizures	49334
1000013	1	2.1		62051
1000013	3	2	Seizures	62051
1000013	1	2.1		50202
1000013	3	1	Seizures, Admit	50202
1000013	1	1		45759
1000013	3	1	Anticoagulants, Petechiae	45759
1000013	1	1		45770
1000013	3	1	Anticoagulants, Petechiae	45770
1000013	1	2.1		44715
1000013	3	1	Opioids, Unarousable	44715
1000013	1	2.1		46136
1000013	3	1	Alcohol	46136
1000013	1	2.1		44003
1000013	3	2	Alcohol, Unarousable	44003
1000013	1	2.1		50984
1000013	3	2	Alcohol, Unarousable	50984
1000013	1	2.1		45049
1000013	3	1	Alcohol, Unarousable	45049
1000013	1	2.1		45788
1000013	3	1	Alcohol	45788
1000013	1	2.1		45793
1000013	3	1	Alcohol, Unarousable	45793
1000013	1	2.1		45752
1000013	3	1	Alcohol, Unarousable - Septic Workup	45752
1000013	1	2.1		45901
1000013	3	1	Alcohol, Unarousable - Septic Workup	45901
1000013	1	2.1		45751
1000013	3	1	Alcohol, Unarousable - Septic Workup	45751
1000013	1	2.1		45873
1000013	3	1	Alcohol, Unarousable - Septic Workup	45873
1000013	1	2.1		45782
1000013	3	1	Alcohol, Unarousable - Septic Workup	45782
1000013	1	2.1		45818
1000013	3	1	Alcohol, Unarousable - Septic Workup	45818
1000013	1	2.1		45801
1000013	3	1	Alcohol, Unarousable - Septic Workup	45801
1000013	1	1		45827
1000013	3	1	Unarousable	45827
1000013	1	1		44682
1000013	3	1	Unarousable	44682
1000013	1	2.1		45763
1000013	3	2	Unarousable - Electrolytes	45763
1000013	1	2.1		45771
1000013	3	2	Unarousable - Electrolytes	45771
1000013	1	2.1		45772
1000013	3	1	Unarousable	45772
1000013	1	2.1		45866
1000013	3	1	Unarousable	45866
1000013	1	2.1		48599
1000013	3	2.5	Unarousable - Cervical Spine Immobilization	48599
1000013	1	2.1		51261
1000013	3	2.5	Unarousable - Cervical Spine Immobilization	51261
1000013	1	2.1		49965
1000013	3	2.5	Unarousable - Cervical Spine Immobilization	49965
1000013	1	2.1		48524
1000013	3	2.5	Unarousable - Cervical Spine Immobilization	48524
1000013	1	2.1		45887
1000013	3	2		45887
1000013	1	2.1		46217
1000013	3	2		46217
1000013	1	1		45760
1000013	3	2	CO Poisoning, Hypoventilation - CO Hgb	45760
1000013	1	2.1		44276
1000013	3	2	Agitated, Delirium Tremens - Chemical restraint	44276
1000013	1	2.1		46889
1000013	3	2	Agitated - Chemical restraint	46889
1000013	1	2.1		45941
1000013	3	2	Agitated - Toxicology	45941
1000013	1	2.1		46236
1000013	3	2	Agitated, Breather Odor, Ethanol - Toxicology	46236
1000013	1	2.1		49134
1000013	3	2	Hypertension	49134
1000013	1	2.1		48561
1000013	3	2	Hypertension	48561
1000013	1	2.1		45838
1000013	3	2	Hypertension - End-Organ Damage Assessment	45838
1000013	1	2.1		45870
1000013	3	2	Hypertension - End-Organ Damage Assessment	45870
1000013	1	2.1		45914
1000013	3	2	Hypertension - End-Organ Damage Assessment	45914
1000013	1	2.1		44198
1000013	3	2	Tachycardia - Crystalloid Challenge	44198
1000013	1	2.1		44290
1000013	3	2	Tachycardia - Crystalloid Challenge	44290
1000013	1	2.1		43997
1000013	3	2	Fever - Antibiotics	43997
1000013	1	2.1		35733
1000013	3	2	Fever - Antibiotics	35733
1000013	1	2.1		44237
1000013	3	2	Fever - Antibiotics	44237
1000013	1	2.1		44391
1000013	3	2	Fever - Antibiotics	44391
1000013	1	2.1		44252
1000013	3	2	Fever - Antibiotics	44252
1000013	1	2.1		44299
1000013	3	2.5	Fever - Antibiotics	44299
1000013	1	2.1		35849
1000013	3	2.5	Fever - Antibiotics	35849
1000013	1	2.1		44615
1000013	3	2	Fever - Antibiotics	44615
1000013	1	2.1		50267
1000013	3	2	Asterixis - Evaluate GI Bleed	50267
1000013	1	2.1		45895
1000013	3	1	Rigidity	45895
1000013	1	2.1		45910
1000013	3	2	Hepatic encephalopathy	45910
1000013	1	2.1		46090
1000013	3	1	Petechiae, Neuro Deficit	46090
1000013	1	2.1		63752
1000013	3	2.5	Breath Odor	63752
1000013	1	2.1		44281
1000013	3	2	Fever - Antipyretic	44281
1000013	1	2.1		56492
1000013	3	2	Fever - Antipyretic	56492
1000013	1	2.1		44213
1000013	3	2.5	Delirium Tremens	44213
1000013	3	2.5	Neuroleptic Malignant Syndrome - Bromocriptine	
1000013	3	2.5	Neuroleptic Malignant Syndrome - Dantrolene	
1000013	1	1		49207
1000013	3	2	Admit	49207
1000013	1	2.1		49678
1000013	3	2	Suicide/Homicide Potential - Consult/Admit	49678
1000026	1	2.1		44595
1000026	3	2	page 261-262 concern for sepsis including CNS infection	44595
1000026	1	2.1		44302
1000026	3	2	page 258 HE discussed	44302
1000026	1	2.1		63811
1000026	3	1	page 257, 258	63811
1000026	1	1		49207
1000026	3	2	page 259	49207
1000026	1	1		50202
1000026	3	1	page 258	50202
1000026	1	1		49678
1000026	3	2	260 psychiatric etiologies	49678
1000026	1	2.1		51261
1000026	3	1	page 259, 263	51261
1000026	1	1		45811
1000026	3	1	p259-260, if too lethargic for POs, might aspirate	45811
1000026	1	2.1		45866
1000026	3	1	p259-260, shotgun approach for patient	45866
1000026	1	2.1		45983
1000026	3	1	page 257-260	45983
1000026	1	2.5		49965
1000026	3	2	page 257 re: trauma	49965
1000026	1	2.5		48524
1000026	3	2	page 257 re: trauma	48524
1000026	1	2.5		48599
1000026	3	2	page 257 re: trauma	48599
1000026	1	2.1		45818
1000026	3	2	page 259 septic work-up includes PNA	45818
1000026	1	2.1		45801
1000026	3	2	page 259 septic work-up includes PNA	45801
1000026	1	2.5		45889
1000026	3	1	page 253 - MRI not readily available in many ERs, does not permit close monitoring, etc.	45889
1000026	1	2.5		46039
1000026	3	1	page 253 - MRI not readily available in many ERs, does not permit close monitoring, etc.	46039
1000026	1	2.5		46065
1000026	3	1	page 253 - MRI not readily available in many ERs, does not permit close monitoring, etc.	46065
1000026	1	1		45760
1000026	3	1	261 hypoventilation	45760
1000026	1	2.1		48829
1000026	3	2	260 psych etiology	48829
1000026	1	2.5		45823
1000026	3	2	if hemorrhage	45823
1000026	1	2.5		63752
1000026	3	2		63752
1000026	1	2.1		45752
1000026	3	1	p259-260, shotgun approach for patient	45752
1000026	1	2.1		45901
1000026	3	1	p259-260, shotgun approach for patient	45901
1000026	1	2.1		46217
1000026	3	1	p259-260, shotgun approach for patient	46217
1000026	1	2.5		45887
1000026	3	1	p259-260, shotgun approach for patient	45887
1000026	1	2.1		45788
1000026	3	1	p259-260, shotgun approach for patient	45788
1000026	1	2.1		45793
1000026	3	1	p259-260, shotgun approach for patient	45793
1000026	1	2.1		45895
1000026	3	2	page 250-260, implied if found down, consider rhabdo	45895
1000026	1	2.1		49083
1000026	3	1	page 257, 258	49083
1000026	1	2.1		48880
1000026	3	1	page 257, 258	48880
1000026	1	2.1		48577
1000026	3	1	page 257, 258	48577
1000026	1	2.1		49020
1000026	3	1	page 257, 258	49020
1000026	1	2.1		45941
1000026	3	1	260	45941
1000026	1	2.1		45910
1000026	3	1	p 262	45910
1000026	1	2.1		62051
1000026	3	2	p 258 consider seizure d/o 	62051
1000026	1	2.1		45763
1000026	3	1	p259-260, shotgun approach for patient	45763
1000026	1	2.1		45771
1000026	3	1	p259-260, shotgun approach for patient	45771
1000026	1	2.1		45806
1000026	3	1	p259-260, shotgun approach for patient	45806
1000026	1	2.1		46136
1000026	3	1	page 263-264 suspect liver pathology	46136
1000026	1	1		49301
1000026	3	1	261 hypoventilation	49301
1000026	1	2.1		46020
1000026	3	2	p259-260, shotgun approach for patient	46020
1000026	1	2.1		45838
1000026	3	2	p259-260, shotgun approach for patient	45838
1000026	1	2.1		49334
1000026	3	2	p 258 consider seizure d/o 	49334
1000026	1	2.1		45778
1000026	3	2	p259-260, shotgun approach for patient	45778
1000026	1	2.1		46090
1000026	3	2	p259-260, shotgun approach for patient	46090
1000026	1	2.1		45759
1000026	3	1	page 263-264 suspect liver pathology	45759
1000026	1	2.1		45770
1000026	3	1	page 263-264 suspect liver pathology	45770
1000026	1	2.1		45792
1000026	3	2	infection considered	45792
1000026	1	2.1		49173
1000026	3	2	260 psych etiology	49173
1000026	1	2.5		45879
1000026	3	2	page 259 i.e. ICH	45879
1000026	1	2.1		45870
1000026	3	2	p259-260, shotgun approach for patient	45870
1000026	1	2.1		45772
1000026	3	1	p259-260, shotgun approach for patient	45772
1000026	1	2.5		45945
1000026	3	2	if hemorrhage	45945
1000026	1	2.1		45751
1000026	3	1	p259-260, shotgun approach for patient	45751
1000026	1	2.1		45873
1000026	3	1	p259-260, shotgun approach for patient	45873
1000026	1	2.1		49134
1000026	3	1	page 260	49134
1000026	1	2.1		45782
1000026	3	1	p259-260, shotgun approach for patient	45782
1000026	1	2.1		46236
1000026	3	2	page 258 re: alcohol use	46236
1000026	1	2.1		44290
1000026	3	2	261 - tachycardia, crystalloid challenge	44290
1000026	1	2.1		44252
1000026	3	2	page 261-262 concern for sepsis including CNS infection	44252
1000026	1	2.1		44237
1000026	3	2	page 261-262 concern for sepsis including CNS infection	44237
1000026	1	2.1		44391
1000026	3	2	page 261-262 concern for sepsis including CNS infection	44391
1000026	1	2.1		46200
1000026	3	1	p259-260, shotgun approach for patient	46200
1000026	1	1		45787
1000026	3	2	implied as part of admission process	45787
1000026	1	1		45854
1000026	3	2	implied as part of admission process	45854
1000026	1	2.1		45955
1000026	3	2	p259-260, shotgun approach for patient	45955
1000026	1	2.1		45914
1000026	3	2	p259-260, shotgun approach for patient	45914
1000026	1	2.1		48561
1000026	3	1	page 260	48561
1000026	1	2.1		50267
1000026	3	2	p259-260, shotgun approach for patient	50267
1000026	1	2.1		46101
1000026	3	2	page 258 discussing seizure	46101
1000026	1	1		45776
1000026	3	2	implied as part of admission process	45776
1000026	1	1		45758
1000026	3	2	implied as part of admission process	45758
1000026	1	1		45921
1000026	3	1	p 261 O2 for hypoventilation	45921
1000026	1	1		45049
1000026	3	1	259-260	45049
1000026	1	2.1		43997
1000026	3	2	page 261-262 concern for sepsis including CNS infection	43997
1000026	1	2.1		56492
1000026	1	2.1		44281
1000026	3	1	p 261 temperature reduction if fever	56492
1000026	3	1	p 261 temperature reduction if fever	44281
1000026	1	2.1		35849
1000026	3	2	page 261-262 concern for sepsis including CNS infection	35849
1000026	1	2.1		44255
1000026	3	2	page 261-262 concern for sepsis including CNS infection	44255
1000026	1	2.1		35733
1000026	3	2	page 261-262 concern for sepsis including CNS infection	35733
1000026	1	2.1		44615
1000026	3	2	page 261-262 concern for sepsis including CNS infection	44615
1000026	1	2.5		44319
1000026	3	2	generally avoid if already altered	44319
1000026	1	2.1		44424
1000026	3	2	page 258 HE discussed	44424
1000026	1	2.1		44003
1000026	3	2	page 258 chronic EtOH	44003
1000026	1	2.1		50984
1000026	3	2	page 258 chronic EtOH	50984
1000026	1	2.1		44682
1000026	3	2	throughout, patient might have hypoglycemia, thiamine first if suspect Wernicke Korsakoff	44682
1000026	1	2.1		46889
1000026	3	2	page 260 for agitated patient consider potential for violence	46889
1000026	1	2.1		44222
1000026	3	2	implied for admit	44222
1000026	1	2.1		44276
1000026	3	1	page 258 withdrawal syndromes, page 266 serotonin syndrome, NMS, withdrawal common, others less so	44276
1000026	1	2.5		44213
1000026	3	1	page 266 re: DTs (?fairly rare)	44213
1000026	1	1		44715
1000026	3	1	page 259	44715
1000026	1	2.1		44299
1000026	3	2	page 261-262 concern for sepsis including CNS infection	44299
1000026	1	2.1		44198
1000026	3	2	261 - tachycardia, crystalloid challenge	44198
1000016	1	1		49251
1000016	3	1	page 2	49251
1000016	1	1		45811
1000016	3	2	pending urgent procedures	45811
1000016	1	2.1		45824
1000016	3	2	in patients with CV risk factors	45824
1000016	1	1		61832
1000016	3	1	page 2	61832
1000016	1	2.1	TEE for pts with renal insufficiency or allergy to contrast dye if suspect aortic pathology	45963
1000016	3	1	page 22	45963
1000016	1	1		62083
1000016	3	1	page 2,7 low risk pt management	62083
1000016	1	1		52590
1000016	3	1	page 2,7 low risk pt management	52590
1000016	1	1		45866
1000016	3	1	page 2 first step is EKG	45866
1000016	1	1		62037
1000016	3	1	page 2	62037
1000016	1	1		48522
1000016	3	2	page 5 alternative causes	48522
1000016	1	2		48676
1000016	3	1	page 5 alternative causes	48676
1000016	1	2.5		45762
1000016	3	2	page 5 alternative causes	45762
1000016	1	2.1		48698
1000016	3	1	page 2 for coronary CT	48698
1000016	1	1		45818
1000016	3	1	page 5 alternative causes	45818
1000016	1	1		45801
1000016	3	1	page 5 alternative causes	45801
1000016	1	2.1		45797
1000016	3	2	as part of risk factor assessment in this population	45797
1000016	1	2.5	if hypoxic should see on O2 sat	45760
1000016	3	1	page 5	45760
1000016	1	2.1		45788
1000016	3	2	starting anticoagulation, considering alternative dx like PNA	45788
1000016	1	2.1		45793
1000016	3	2	starting anticoagulation, considering alternative dx like PNA	45793
1000016	1	2.5	not primary marker	45895
1000016	3	1	page 17	45895
1000016	1	1		48532
1000016	3	1	page 5 alternative causes	48532
1000016	1	2.1		45891
1000016	3	2	starting anticoagulation, considering alternative dx like PNA	45891
1000016	1	1		63714
1000016	3	1	page 19	63714
1000016	1	2.1		61837
1000016	3	2	as part of risk factor assessment in this population	61837
1000016	1	2.5	not primary marker	45892
1000016	3	1	page 17	45892
1000016	1	2.1		45763
1000016	3	2	Cr	45763
1000016	1	2.5		45771
1000016	3	2		45771
1000016	1	2.1		45806
1000016	3	2	page 4 arrythmic complications	45806
1000016	1	2.5		45853
1000016	3	2	not mentioned for diagnosis of ACS	45853
1000016	1	1		46098
1000016	3	1	discussion page 2 or numerous tings that would require constrast	46098
1000016	1	1		45838
1000016	3	1	page 16, 17	45838
1000016	1	1		46090
1000016	3	1	page 19, need to get if heparinizing	46090
1000016	1	1		45759
1000016	3	1	page 19, need to get if heparinizing	45759
1000016	1	1		45770
1000016	3	1	page 19, need to get if heparinizing	45770
1000016	1	2.5		45879
1000016	3	2	page 5 chest tube	45879
1000016	1	1		45870
1000016	3	1	page 16, 17	45870
1000016	1	2.1		45787
1000016	3	2	implied for patients being admitted	45787
1000016	1	2.1		45854
1000016	3	2	implied for patients being admitted	45854
1000016	1	2.5		45955
1000016	3	2		45955
1000016	1	1		46064
1000016	3	1	discussion page 2 or numerous tings that would require constrast	46064
1000016	1	2.1		46185
1000016	3	1	page 5 ABG specifically mentioned	46185
1000016	1	1		45914
1000016	3	1	page 16, 17	45914
1000016	1	2.1		45776
1000016	3	2	implied for patients being admitted	45776
1000016	1	2.1		45758
1000016	3	2	implied for patients being admitted	45758
1000016	1	1		45921
1000016	3	1	page 2	45921
1000016	1	1		44206
1000016	1	1		44315
1000016	3	1		44206
1000016	3	1	page 2 first step is ASA	44315
1000016	1	1		44212
1000016	3	1	page 18	44212
1000016	1	2.5		44319
1000016	3	2	page 16 only morphine mentioned	44319
1000016	1	2.5		44236
1000016	3	2	GI causes in differential for alternative causes	44236
1000016	1	2	if recurrent symptoms despite beta blockers	44241
1000016	1	1		44256
1000016	1	2.5		44285
1000016	3	1	page 20 	44241
1000016	3	1	page 20 	44256
1000016	3	2		44285
1000016	1	2.1		44222
1000016	3	2	as part of admisison	44222
1000016	1	2		47006
1000016	3	1	page 18, prasugrel with more limitations than clopidogrel, ?should not be part of order set	47006
1000016	1	1		44294
1000016	3	1	page 16	44294
1000016	1	2.1		44240
1000016	3	2	STEMI algorithm -> 2nd risk factor modification	44240
1000016	1	2.1		44198
1000016	3	2		44198
1000017	1	1		49251
1000017	3	1	page 8 local protocols for STEMI - call cards!	49251
1000017	1	1		45811
1000017	3	2	page 8 local protocols for STEMI - implied if pending procedure	45811
1000017	1	2.1		45824
1000017	3	2	page 15 risk factors for ACS imply healthy diet preferred	45824
1000017	1	1		61832
1000017	3	2	page 12, can look for focal WMA	61832
1000017	1	2.5		45963
1000017	3	2	discussion of indications for echo, TEE generally not needed, for aortic dissection CTA preferred	45963
1000017	1	1		62083
1000017	3	1	page 19 non-invasive testing for select patients	62083
1000017	1	1		52590
1000017	3	1	page 19 non-invasive testing for select patients	52590
1000017	1	1		45866
1000017	3	1	page 7	45866
1000017	1	1		62037
1000017	3	1	page 8 local protocols for STEMI - call cards!	62037
1000017	1	2.1		48522
1000017	3	2	page 9 consider aortic dissection as alternative diagnosis	48522
1000017	1	2.1		48676
1000017	3	2	page 9 consider PE as alternative diagnosis	48676
1000017	1	2.5		45762
1000017	3	2	page 9 consider PE as alternative diagnosis, usually don't simultaneously CT LE	45762
1000017	1	2.1		48698
1000017	3	1	page 19 for CAD CT coronary angiography, technically not just a CT Thorax order	48698
1000017	1	2.1		45818
1000017	3	2	page 9 consider PNA as alternative diagnosis	45818
1000017	1	2.1		45801
1000017	3	2	page 9 consider PNA as alternative diagnosis	45801
1000017	1	1		45797
1000017	3	2	page 15 CV risk factor stratification including DM, lipid abnormalities	45797
1000017	1	2.5		45760
1000017	3	2	page 10 discussion of COPD subset	45760
1000017	1	2.5		45823
1000017	3	2	page 16 identify other conditions such as anemia	45823
1000017	1	2.1		45788
1000017	3	2	consider other causes like PNA page 9	45788
1000017	1	2.1		45793
1000017	3	2	page 16 identify other conditions such as anemia	45793
1000017	1	2.5		45895
1000017	3	2	page 11 discussion of biochemical markers, troponin discussed, CKMB not mentioned	45895
1000017	1	2.1		48532
1000017	3	2	discussion of excluding PE and aortic dissection	48532
1000017	1	2.1		45891
1000017	3	2	page 16 identify other conditions such as anemia	45891
1000017	1	2.1		63714
1000017	3	2	page 9 local protocols regarding ACS	63714
1000017	1	1		61837
1000017	3	2	page 15 CV risk factor stratification including DM, lipid abnormalities	61837
1000017	1	2.5		45892
1000017	3	2	page 11 discussion of biochemical markers, troponin discussed, CKMB not mentioned	45892
1000017	1	2.1		45763
1000017	3	2	need Cr if going to get contrast	45763
1000017	1	2.5		45771
1000017	3	2	not clear that need LFTs etc.	45771
1000017	1	2.5		45806
1000017	3	2		45806
1000017	1	2.5		45853
1000017	3	1	page 11, dont't use to diagnose ACS	45853
1000017	1	2.1		46098
1000017	3	2	need Cr if going to get contrast	46098
1000017	1	1		45838
1000017	3	1	page 7	45838
1000017	1	2.1		46090
1000017	3	2	might start heparin per protocols on page 9	46090
1000017	1	2.1		45759
1000017	3	2	might start heparin per protocols on page 9	45759
1000017	1	2.1		45770
1000017	3	2	might start heparin per protocols on page 9	45770
1000017	1	2.5		45879
1000017	3	2	presumably some people eventually go to CABG, but this need not be on admission order set	45879
1000017	1	1		45870
1000017	3	1	page 7	45870
1000017	1	2.5		45945
1000017	3	2	page 16 identify other conditions such as anemia	45945
1000017	1	2.1		45787
1000017	3	2	implied for patients being admitted	45787
1000017	1	2.1		45854
1000017	3	2	implied for patients being admitted	45854
1000017	1	2.5		45955
1000017	3	2	risk stratification	45955
1000017	1	2.1		46064
1000017	3	2	need Cr if going to get contrast	46064
1000017	1	2.5		46185
1000017	3	2	page 10 discussion of COPD subset	46185
1000017	1	1		45914
1000017	3	1	page 7	45914
1000017	1	2.1		45776
1000017	3	2	implied for patients being admitted	45776
1000017	1	2.1		45758
1000017	3	2	implied for patients being admitted	45758
1000017	1	2		45921
1000017	3	1	page 9 don't routinely offer it but give if hypoxic	45921
1000017	1	1		44206
1000017	1	1		44315
1000017	3	1	page 9 ASA for suspected ACS	44206
1000017	3	1	page 9 ASA for suspected ACS	44315
1000017	1	2.1		44212
1000017	3	2	page 9 "other antiplatelet agents"	44212
1000017	1	2.1		44319
1000017	3	1	page 9 re: "offer intravenous opioids such as morphine"	44319
1000017	1	2.5		44236
1000017	3	2	page 16 consider non-cardiac causes CP, which would include GERD	44236
1000017	1	2.5		44241
1000017	1	1	page 9	44256
1000017	1	2.5		44285
1000017	3	2	page 9, although only sublingual/buccal mentioned	44241
1000017	3	1	page 9 	44256
1000017	3	2	page 9, although only sublingual/buccal mentioned	44285
1000017	1	2.1		44222
1000017	3	2	implied for admit	44222
1000017	1	2.1		47006
1000017	3	2	page 9 "other antiplatelet agents"	47006
1000017	1	2.1		44294
1000017	3	1	page 9 re: "offer intravenous opioids such as morphine"	44294
1000017	1	2.1		44240
1000017	3	2	page 15 HL as risk factor	44240
1000017	1	2.1		44198
1000017	3	2	as part of admission, might be needed i.e. if pre-renal or hypotensive etc. 	44198
1000018	1	1		49207
1000018	3	2	page 347	49207
1000018	1	2.5	page 346 risk stratification	49055
1000018	3	2.5		49055
1000018	1	1		49481
1000018	3	2	page 346	49481
1000018	1	2.5	page 346 risk stratification	48502
1000018	3	2.5		48502
1000018	1	2.1		45784
1000018	3	2	page 348 peri-EGD time period	45784
1000018	1	1		45811
1000018	3	2	page 351 plan EGD	45811
1000018	1	1		46008
1000018	3	2	page 351 plan EGD	46008
1000018	1	2		45866
1000018	3	2	page 346, 347 risk stratification, including cardiac disease changing transfusion thresholds	45866
1000018	1	1		45969
1000018	3	1	page 346	45969
1000018	1	2.5		46072
1000018	3	2.5	page 346 risk stratification	46072
1000018	1	2.5		45858
1000018	3	2.5	page 346 risk stratification	45858
1000018	1	2.5		45852
1000018	3	2.5	page 346 risk stratification	45852
1000018	1	2.5		45818
1000018	3	2	page 347 discusses risk of aspiration	45818
1000018	1	1		45823
1000018	3	2	page 346	45823
1000018	1	1		45927
1000018	3	2	page 346	45927
1000018	1	2.5		45788
1000018	3	2	page 345	45788
1000018	1	1		45793
1000018	3	1	page 345 "laboratory tests"	45793
1000018	1	1		63759
1000018	3	2	page 346, 347	63759
1000018	1	1		45891
1000018	3	1	page 345 "laboratory tests"	45891
1000018	1	2.1		45948
1000018	3	2	page 346, 355 = explicitly discuss H pylori biopsy testing, but earlier state low risk patients can be discharged without endoscopy, ?implies using non-invasive testing in those patients?	45948
1000018	1	2.1		48724
1000018	3	2	page 346, 355	48724
1000018	1	2.1		45918
1000018	3	2	page 346 risk stratification	45918
1000018	1	2.1		45894
1000018	3	2	page 345	45894
1000018	1	2.1		45763
1000018	3	2	page 346 risk stratification	45763
1000018	1	2.1		45771
1000018	3	2	page 346 risk stratification	45771
1000018	1	2.1		45806
1000018	3	2	page 346 risk stratification	45806
1000018	1	2.1		46020
1000018	3	2	page 346 risk stratification	46020
1000018	1	2.1		45888
1000018	3	2	page 346 risk stratification	45888
1000018	1	2		45838
1000018	3	2	page 346, 347 risk stratification, including cardiac disease changing transfusion thresholds	45838
1000018	1	2.1		45759
1000018	3	2	page 346 risk stratification	45759
1000018	1	2.1		45770
1000018	3	2	page 346 risk stratification	45770
1000018	1	2.5	page 346 risk stratification	45879
1000018	3	2.5		45879
1000018	1	2		45870
1000018	3	2	page 346, 347 risk stratification, including cardiac disease changing transfusion thresholds	45870
1000018	1	1		45945
1000018	3	2	page 346	45945
1000018	1	2.1		44233
1000018	3	2		44233
1000018	1	1		65640
1000018	3	2	page 346	65640
1000018	1	2.1		61993
1000018	3	2	page 346 risk stratification	61993
1000018	1	1		61975
1000018	3	2	page 346	61975
1000018	1	2.5	page 346 risk stratification	46192
1000018	3	2.5		46192
1000018	1	2.1		45955
1000018	3	2	page 346 risk stratification	45955
1000018	1	2		45914
1000018	3	2	page 346, 347 risk stratification, including cardiac disease changing transfusion thresholds	45914
1000018	1	2.1		50267
1000018	3	2	risk stratification -> not so much for occult blood but for assessment of brown stool, melena, BRBPR	50267
1000018	1	2.5		45832
1000018	3	2	page 347 discussing intubation	45832
1000018	1	3		47146
1000018	3	1	page 347 - don't use in acute setting so should not be on admission order set	47146
1000018	1	2.1		44319
1000018	3	2	page 347 discussing admission	44319
1000018	1	2		44592
1000018	3	1	page 346	44592
1000018	1	1	evidence weaker for pre-endoscopic, but strong recommendation post endoscopy)	44219
1000018	1	1	page 346 strong rec	44236
1000018	3	1	page 346	44219
1000018	3	1	page 346	44236
1000018	1	2.5		52294
1000018	3	2	page 347 risk stratification	52294
1000018	1	2.5		46722
1000018	3	2	page 347 risk stratification	46722
1000018	1	3		44222
1000018	3	2	page 347	44222
1000018	1	2.5		44001
1000018	3	2	page 347 risk stratification	44001
1000018	1	2.1		44198
1000018	3	2	page 347 risk strafication including BP, volume depletion	44198
1000019	1	1		49207
1000019	3	2	page 1-2, implied by need for admission	49207
1000019	1	1		49055
1000019	3	2	implied by possible need for surgery (page 2) if IR not available, pendign what was seen	49055
1000019	1	1		49481
1000019	3	2	page 1-2, need for endoscopy	49481
1000019	1	1		48502
1000019	3	2	page 1-2, implied by recommendation for IR procedure in unstable patient, etc.	48502
1000019	1	1		45811
1000019	3	2	implied by need for various procedures	45811
1000019	1	1		46008
1000019	3	2	implied by need for various procedures	46008
1000019	1	2.1		45866
1000019	3	2	page 1/2, assess hemodynamic stability	45866
1000019	1	1		50005
1000019	3	1	page 1	50005
1000019	1	1		45969
1000019	3	1	page 1 "upper endoscopy should also be considered in patients with brisk bleeding"	45969
1000019	1	2.5		46072
1000019	3	2	page 1 and 2	46072
1000019	1	2.5		45858
1000019	3	2	page 1 and 2	45858
1000019	1	1		45852
1000019	3	2	page 1 and 2 -> actually specifically a CTA	45852
1000019	1	1		45823
1000019	3	2	page 2 discussing units of blood required	45823
1000019	1	1		45927
1000019	3	2	page 2 discussing units of blood required	45927
1000019	1	2.1		45788
1000019	3	2		45788
1000019	1	1		45793
1000019	3	2	page 1 and 2, need to risk stratify	45793
1000019	1	1		63759
1000019	3	2	page 2 discussing units of blood required	63759
1000019	1	1		45891
1000019	3	2	page 1 and 2, need to risk stratify	45891
1000019	1	2.1	page 1 if brisk bleeding consider UGIB	45948
1000019	3	2		45948
1000019	1	2.1	page 1 if brisk bleeding consider UGIB	48724
1000019	3	2		48724
1000019	1	2.1		45918
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45918
1000019	1	2.1		45763
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45763
1000019	1	2.1		45771
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45771
1000019	1	2.1		45806
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45806
1000019	1	2.1		46020
1000019	3	2	page 1nad 2 regarding hemodynamic stability	46020
1000019	1	2.1		45888
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45888
1000019	1	2.1		45838
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45838
1000019	1	2.1		45759
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45759
1000019	1	2.1		45770
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45770
1000019	1	2.1		45879
1000019	3	1	page 2	45879
1000019	1	2.1		45870
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45870
1000019	1	1		45945
1000019	3	2	page 2 discussing units of blood required	45945
1000019	1	1		46427
1000019	3	2	implied by page 1-2, colonoscopy recommended	46427
1000019	1	2.1		44233
1000019	3	2	many possible procedures possible	44233
1000019	1	1		65640
1000019	3	2	page 2 discussing units of blood required	65640
1000019	1	2.1		61993
1000019	3	2	as part of overall effort to stop bleeding	61993
1000019	1	1		61975
1000019	3	2	page 2 discussing units of blood required	61975
1000019	1	2.1		46192
1000019	3	1	page 2	46192
1000019	1	2.1		45955
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45955
1000019	1	2.1		45914
1000019	3	2	page 1nad 2 regarding hemodynamic stability	45914
1000019	1	2.1		35733
1000019	3	2	page 1 consider UGIB if brisk bleeding, of UGIB, variceal bleed is one of those that can be most severe	35733
1000019	1	2.1		44249
1000019	1	2.1		44262
1000019	3	2	page 1 consider UGIB if brisk bleeding, of UGIB, variceal bleed is one of those that can be most severe	44249
1000019	3	2	page 1 consider UGIB if brisk bleeding, of UGIB, variceal bleed is one of those that can be most severe	44262
1000019	1	2.1		44319
1000019	3	2		44319
1000019	1	2.1		44592
1000019	3	2	page 1 consider UGIB	44592
1000019	1	2.1		44219
1000019	1	2.1	page 1 consider UGIB if brisk bleeding	44236
1000019	3	2		44219
1000019	3	2	page 1 consider UGIB if brisk bleeding	44236
1000019	1	2.5		52294
1000019	3	2	implied in catastrophic settings	52294
1000019	1	2.5		46722
1000019	3	2	implied in catastrophic settings	46722
1000019	1	2.1		43996
1000019	3	2	page 1 consider UGIB if brisk bleeding, of UGIB, variceal bleed is one of those that can be most severe	43996
1000019	1	2.1		44001
1000019	3	2		44001
1000019	1	1		44198
1000019	3	2	p1, p2, discussing hemodynamic stability	44198
1000020	1	2.1		49867
1000020	3	1	page 8	49867
1000020	1	2.1		46028
1000020	3	1	page 8 	46028
1000020	1	1		49207
1000020	3	2	page 4 almost everyone treated as inpatient	49207
1000020	1	1		49055
1000020	3	2	page 4 "emergency surgery may be needed	49055
1000020	1	1		49481
1000020	3	2	page 4 EGD primary test	49481
1000020	1	1		48502
1000020	3	2	"IR may be needed"	48502
1000020	1	2.1		45784
1000020	3	2	peri-procedure?	45784
1000020	1	1		45811
1000020	3	2	pre-procedure	45811
1000020	1	1		46008
1000020	3	2	pre-procedure	46008
1000020	1	2.1		45866
1000020	3	2	page 8 risk assessment 	45866
1000020	1	1		45969
1000020	3	1	page 4	45969
1000020	1	2.5		46072
1000020	3	2	discussion of surgery and or IR in intro, but would need contrast ideally	46072
1000020	1	2.5		45858
1000020	3	2	discussion of surgery and or IR in intro, but would need contrast ideally	45858
1000020	1	2.1		45852
1000020	3	2	discussion of surgery and or IR in intro, but would need contrast ideally, would actually be CTA?	45852
1000020	1	1		45823
1000020	3	2	page 8 discussion of blood transfusion	45823
1000020	1	1		45927
1000020	3	1	page 8 discussion of blood transfusion	45927
1000020	1	1		45788
1000020	3	1	page 8 risk assessment with blatchford score	45788
1000020	1	1		45793
1000020	3	1	page 8 risk assessment with blatchford score	45793
1000020	1	1		63759
1000020	3	1	page 8 discussion of blood transfusion	63759
1000020	1	1		45891
1000020	3	1	page 8 risk assessment with blatchford score	45891
1000020	1	2.1		45948
1000020	3	2	discussion that ulcers most common cause of bleed in intro	45948
1000020	1	2.1		48724
1000020	3	2		48724
1000020	1	2		45918
1000020	3	1	page 8 risk assessment	45918
1000020	1	1		45763
1000020	3	1	page 8 risk assessment with blatchford score	45763
1000020	1	1		45771
1000020	3	1	page 8 risk assessment with blatchford score	45771
1000020	1	2.1		45806
1000020	3	2	page 8 risk assessment with blatchford score	45806
1000020	1	2.1		46020
1000020	3	1	page 8 risk assessment with blatchford score	46020
1000020	1	2.1		45888
1000020	3	1	page 8 risk assessment with blatchford score	45888
1000020	1	2.1		45838
1000020	3	1	page 8 risk assessment with blatchford score	45838
1000020	1	2.1		45759
1000020	3	1	page 8 discussion of indiications for FFP	45759
1000020	1	2.1		45770
1000020	3	1	page 8 discussion of indiications for FFP	45770
1000020	1	2.5	would wait for surgery consult first	45879
1000020	3	2	emergency surgery may be needed	45879
1000020	1	2.1		45870
1000020	3	1	page 8 risk assessment with blatchford score	45870
1000020	1	1		45945
1000020	3	1	page 8 discussion of blood transfusion	45945
1000020	1	2.1		44233
1000020	3	2	implied if needed for EGD	44233
1000020	1	1		65640
1000020	3	1	page 8 discussion of blood transfusion	65640
1000020	1	2.1		61993
1000020	3	1	page 8 FFP with active bleeding	61993
1000020	1	1		61975
1000020	3	1	page 8 discussion of blood transfusion	61975
1000020	1	2.1		45787
1000020	3	2	as part of hospitalization, particularly if elderly or other co-morbidities	45787
1000020	1	2.1		45854
1000020	3	2	as part of hospitalization, particularly if elderly or other co-morbidities	45854
1000020	1	2.5		46192
1000020	3	1	emergency surgery may be needed	46192
1000020	1	2.1		45955
1000020	3	1	page 8 risk assessment with blatchford score	45955
1000020	1	2.1		45914
1000020	3	1	page 8 risk assessment with blatchford score	45914
1000020	1	2.5		50267
1000020	3	2	risk stratification (not so much to look for occult blood though, more to actually do rectal)	50267
1000020	1	2.1		45776
1000020	3	2	as part of hospitalization, particularly if elderly or other co-morbidities	45776
1000020	1	2.1		45758
1000020	3	2	as part of hospitalization, particularly if elderly or other co-morbidities	45758
1000020	1	2.5		45832
1000020	3	2	subset of critically ill pts	45832
1000020	1	2.5		47146
1000020	3	1	page 7, continue ASA if not bleeding and need it for CV risk prevention	47146
1000020	1	2.1		35733
1000020	3	2	page 10 prophylactic abx if suspect bleeding	35733
1000020	1	2.5		44249
1000020	1	2.1		44262
1000020	3	2.5	page 10 prophylactic abx if suspect bleeding	44249
1000020	3	2	page 10 prophylactic abx if suspect bleeding	44262
1000020	1	2.1		44319
1000020	3	2	as part of admission	44319
1000020	1	2.1		44592
1000020	3	2	implied since EGD so important on page 1	44592
1000020	1	2		44219
1000020	1	2		44236
1000020	3	1	page 9 and 11, PPI use depends on risk	44219
1000020	3	1	page 9 and 11, PPI use depends on risk	44236
1000020	1	2.1		52294
1000020	3	2	Page 8 PCC recommended if taking warfarin and actively bleeding (actually would be quite a few patients, PCC not part of our practice in US but this recommendaiton sounds pretty clear	52294
1000020	1	2.5		46722
1000020	3	2	Page 8 PCC recommended if taking warfarin and actively bleeding but page 9 don't use 7a unless all other methods failed	46722
1000020	1	3		44222
1000020	3	2	as part of admission, presumably hold in setting of acute bleeding	44222
1000020	1	2.1		43996
1000020	3	2	terlipressin mentioned in EV section, octreotide ?equivalent in outcomes	43996
1000020	1	2.1		44001
1000020	3	2	implied page 8 discussing FFP, PCC, not clear that IV is preferred route	44001
1000020	1	2		44198
1000020	3	2	implied in terms of admission	44198
1000021	1	1		49207
1000021	3	2	page 4 (implied, for inpatient management)	49207
1000021	1	2.5		49055
1000021	3	2	page 6 splenorenal shunt	49055
1000021	1	1		49481
1000021	3	2	page 2 (EGD is gold standard)	49481
1000021	1	1		48502
1000021	3	2	page 4, TIPS in some instances	48502
1000021	1	2.5		45784
1000021	3	2		45784
1000021	1	1		45811
1000021	3	2	page 2 (EGD is gold standard)	45811
1000021	1	1		46008
1000021	3	2	page 2 (EGD is gold standard)	46008
1000021	1	2.1		45866
1000021	3	2	page 5 variceal bleed, risk stratification	45866
1000021	1	1		45969
1000021	3	1	page 2 (EGD is gold standard)	45969
1000021	1	2.5		46072
1000021	3	2	page 6 (considering TIPs)	46072
1000021	1	2.5		45858
1000021	3	2	page 6 (considering TIPs)	45858
1000021	1	2.5		45852
1000021	3	2	page 6 (considering TIPs)	45852
1000021	1	2.1		45818
1000021	3	2	page 6 re: "bronchial aspiration of blood"	45818
1000021	1	1		45823
1000021	3	1	page 5, "blood transfusion"	45823
1000021	1	1		45927
1000021	3	1	page 5, "blood transfusion"	45927
1000021	1	1		45788
1000021	3	2	page 5 variceal bleed, risk stratification, also often associated with bacterial infection	45788
1000021	1	1		45793
1000021	3	2	page 5 variceal bleed, risk stratification	45793
1000021	1	1		63759
1000021	3	1	page 5, "blood transfusion"	63759
1000021	1	1		45891
1000021	3	2	page 5 variceal bleed, risk stratification	45891
1000021	1	2.1		45948
1000021	3	2	page3 PUD more common in cirrhotics	45948
1000021	1	2.1		48724
1000021	3	2	page3 PUD more common in cirrhotics	48724
1000021	1	1		45918
1000021	3	2	page 5 variceal bleed, risk stratification	45918
1000021	1	1		45763
1000021	3	2	page 5 variceal bleed, risk stratification	45763
1000021	1	1		45771
1000021	3	2	page 5 variceal bleed, risk stratification	45771
1000021	1	1		45806
1000021	3	2	page 5 variceal bleed, risk stratification	45806
1000021	1	2.1		46020
1000021	3	2	page 5 variceal bleed, risk stratification	46020
1000021	1	2.1		45888
1000021	3	2	page 5 variceal bleed, risk stratification	45888
1000021	1	2.1		45838
1000021	3	2	page 5 variceal bleed, risk stratification	45838
1000021	1	1		45759
1000021	3	2	page 5 variceal bleed, risk stratification, also mention in intro re: INR elevations in variceal bleed patients	45759
1000021	1	1		45770
1000021	3	2	page 5 variceal bleed, risk stratification, also mention in intro re: INR elevations in variceal bleed patients	45770
1000021	1	2.5		45879
1000021	3	2	page 6 splenorenal shunt	45879
1000021	1	2.1		45870
1000021	3	2	page 5 variceal bleed, risk stratification	45870
1000021	1	1		45945
1000021	3	1	page 5, "blood transfusion"	45945
1000021	1	1		44233
1000021	3	2	page 2 (EGD is gold standard)	44233
1000021	1	1		65640
1000021	3	1	page 5, "blood transfusion"	65640
1000021	1	1		61993
1000021	3	2	page 5, "blood transfusion", prior discussion page 2 INR elevations	61993
1000021	1	1		61975
1000021	3	1	page 5, "blood transfusion"	61975
1000021	1	2.5		46192
1000021	3	2	page 6 splenorenal shunt	46192
1000021	1	2.1		45955
1000021	3	2	page 5 variceal bleed, risk stratification	45955
1000021	1	2.1		45914
1000021	3	2	page 5 variceal bleed, risk stratification	45914
1000021	1	2.5		45832
1000021	3	2	page 6 tracheal intubation mentioned	45832
1000021	1	1	mortality benefit	35733
1000021	3	1	page 6	35733
1000021	1	1		44249
1000021	1	1		44262
1000021	3	2	PO norfloxacin mentioned, IV copro mentioned	44249
1000021	3	1	page 6	44262
1000021	1	2.1		44319
1000021	3	2	if admitted	44319
1000021	1	2.1		44592
1000021	3	2	EGD recommended	44592
1000021	1	2.1		44219
1000021	1	2.1		44236
1000021	3	2	page 3 PUD more common in cirrhotics	44219
1000021	3	2	page 3 PUD more common in cirrhotics	44236
1000021	1	2.5		52294
1000021	3	2	variceal bleed	52294
1000021	1	2.5		46722
1000021	3	2	variceal bleed	46722
1000021	1	3	(if acute bleeding)	44222
1000021	3	2		44222
1000021	1	2	somatostatin ?better	43996
1000021	3	1	page 4	43996
1000021	1	2.1		44001
1000021	3	2	variceal bleed, INR may be high	44001
1000021	1	1		44198
1000021	3	1	page 5	44198
1000025	1	1		49251
1000025	3	2	page 29 implied for inpatients	49251
1000025	1	1		65695
1000025	3	2	page 43	65695
1000025	1	2.5		45811
1000025	3	2	page 37 if cardiac biopsy needed	45811
1000025	1	2		61989
1000025	3	2	page 44	61989
1000025	1	2		45824
1000025	3	2	page 44, 45	45824
1000025	1	2		61832
1000025	3	1	page 33	61832
1000025	1	2		45866
1000025	3	1	page 29 initial evaluation	45866
1000025	1	2		45818
1000025	3	1	page 33	45818
1000025	1	2		45801
1000025	3	1	page 33	45801
1000025	1	2.5		45823
1000025	3	2	page 101	45823
1000025	1	2		45788
1000025	3	1	page 29 initial lab evaluation	45788
1000025	1	2		45793
1000025	3	1	page 29 initial lab evaluation	45793
1000025	1	2		45910
1000025	3	1	page 29 initial lab evaluation	45910
1000025	1	2		61837
1000025	3	1	page 29 initial lab evaluation	61837
1000025	1	2		45763
1000025	3	1	page 29 initial lab evaluation	45763
1000025	1	2		45771
1000025	3	1	page 29 initial lab evaluation	45771
1000025	1	2		45806
1000025	3	1	page 29 initial lab evaluation	45806
1000025	1	1		45853
1000025	3	1	page 29	45853
1000025	1	1		45838
1000025	3	1	page 29	45838
1000025	1	2		45778
1000025	3	1	page 29 initial lab evaluation	45778
1000025	1	2		45759
1000025	3	1	page 29 initial lab evaluation includes "liver function tests"	45759
1000025	1	2		45770
1000025	3	1	page 29 initial lab evaluation includes "liver function tests"	45770
1000025	1	2.5		45879
1000025	3	2	page 37 if cardiac biopsy needed	45879
1000025	1	1		45870
1000025	3	1	page 29	45870
1000025	1	2.1		45772
1000025	3	2	page 20 thyroid disease implicated in DCM	45772
1000025	1	2.5		45945
1000025	3	2	page 101	45945
1000025	1	2		45751
1000025	3	1	page 29 initial lab evaluation	45751
1000025	1	1		45787
1000025	3	2	page 46 exercise training	45787
1000025	1	1		45854
1000025	3	2	page 46 exercise training	45854
1000025	1	2		50370
1000025	3	1	page 29 initial lab evaluation	50370
1000025	1	1		45914
1000025	3	1	page 29	45914
1000025	1	1		45776
1000025	3	2	page 46 exercise training	45776
1000025	1	1		45758
1000025	3	2	page 46 exercise training	45758
1000025	1	2.5		46030
1000025	3	2	critically ill	46030
1000025	1	3		44296
1000025	3	2	page 64	44296
1000025	1	2.1		44206
1000025	3	2	page 17 risk factors for HF	44206
1000025	1	1		45035
1000025	3	1	page 49-52	45035
1000025	1	1		44686
1000025	3	1	page 90	44686
1000025	1	1		44340
1000025	3	1	page 53	44340
1000025	1	2		44309
1000025	3	1	page 47-49	44309
1000025	1	1		44357
1000025	3	1	page 49-52	44357
1000025	1	3		44428
1000025	3	2	page 64	44428
1000025	1	2		44389
1000025	3	1	page 59 	44389
1000025	1	2.5		44319
1000025	3	2	as part of admission	44319
1000025	1	3		44393
1000025	3	2	page 64	44393
1000025	1	2		46614
1000025	3	1	page 93	46614
1000025	1	3		44301
1000025	3	2	page 64	44301
1000025	1	2		44251
1000025	3	1	page 81	44251
1000025	1	2		44323
1000025	3	1	page 81	44323
1000025	1	1		45190
1000025	3	1	page 49-52	45190
1000025	1	2.5		44297
1000025	3	2	as part of admission	44297
1000025	1	2		44004
1000025	3	1	page 47-49	44004
1000025	1	1		44241
1000025	1	2.5		44256
1000025	1	2.5		44285
1000025	3	1	page 90	44241
1000025	3	2	page 90	44256
1000025	3	2	page 90	44285
1000025	1	1		44374
1000025	3	1	page 49-52	44374
1000025	1	1		44222
1000025	3	2	91	44222
1000025	1	2		45427
1000025	3	1	page 81	45427
1000025	1	1		44412
1000025	3	1	page 58	44412
1000025	1	3		44271
1000025	3	2	page 64	44271
1000025	1	2.5		44242
1000025	3	2	page 58	44242
1000025	1	1		44367
1000025	3	1	page 58	44367
1000025	1	1		44250
1000025	3	2	91	44250
1000025	1	1		44005
1000025	3	1	page 53	44005
1000025	1	1		44347
1000025	3	1	page 49-52	44347
1000025	1	2.5		44352
1000025	3	1	page 65	44352
1000025	1	2.5		44294
1000025	3	2	as part of admission	44294
1000025	1	3		44341
1000025	3	2	page 64	44341
1000025	1	1		35133
1000025	3	1	page 90	35133
1000025	1	2.5		44023
1000025	3	2	as part of admission	44023
1000025	1	2.5		44198
1000025	3	2	discussion of volume overload	44198
1000025	1	2		44430
1000025	3	1	page 55	44430
1000024	1	1		49251
1000024	3	1	page 8, should have cardiology team	49251
1000024	1	1		65695
1000024	3	2	page 8 "team" (should include CNS), page 10 re: f/u	65695
1000024	1	2.1		61989
1000024	3	2	page 12, as part of non-pharmacologic treatment, in patients who may be volume overloaded, etc.	61989
1000024	1	2.1		45824
1000024	3	2	page 12, as part of non-pharmacologic treatment, in patients who may be volume overloaded, etc.	45824
1000024	1	1		61832
1000024	3	1	page 8 	61832
1000024	1	2.1		45866
1000024	3	2	page 8 work-up for suspected HF	45866
1000024	1	2.1		45818
1000024	3	2	page 8 work-up for suspected HF	45818
1000024	1	2.1		45801
1000024	3	2	page 8 work-up for suspected HF	45801
1000024	1	2.1		45788
1000024	3	2	page 8 work-up for suspected HF	45788
1000024	1	2.1		45793
1000024	3	2	page 8 work-up for suspected HF	45793
1000024	1	1		45763
1000024	3	2	page 11 re: monitoring during diuresis	45763
1000024	1	2.1		45771
1000024	3	2	page 8 work-up for suspected HF	45771
1000024	1	1		45806
1000024	3	2	page 11 re: monitoring during diuresis	45806
1000024	1	1		45853
1000024	3	1	page 8	45853
1000024	1	2.1		45838
1000024	3	2	page 8 work-up for suspected HF	45838
1000024	1	2.5		45778
1000024	3	2	page 8 work-up for suspected HF	45778
1000024	1	2.1		45770
1000024	3	2	page 8 work-up for suspected HF - assess for hepatic congestion/dysfunction	45770
1000024	1	2.1		45770
1000024	3	2	page 8 work-up for suspected HF - assess for hepatic congestion/dysfunction	45770
1000024	1	2.5		45879
1000024	3	1	page 13, valvular sugery, etc.	45879
1000024	1	2.1		45870
1000024	3	2	page 8 work-up for suspected HF	45870
1000024	1	2.5		45772
1000024	3	2	page 8 work-up for suspected HF	45772
1000024	1	2.1		45787
1000024	3	1	page 8 "multi-disc care"	45787
1000024	1	2.1		45854
1000024	3	1	page 8 "multi-disc care"	45854
1000024	1	2.1		45914
1000024	3	2	page 8 work-up for suspected HF	45914
1000024	1	2.1		45776
1000024	3	1	page 8 "multi-disc care"	45776
1000024	1	2.1		45758
1000024	3	1	page 8 "multi-disc care"	45758
1000024	1	2.5		46030
1000024	3	1	page 12, do not routinely use	46030
1000024	1	2.5		44296
1000024	3	2	page 13, discusses beta blockers, calcium chanell blockers not indicated in most instances	44296
1000024	1	2.1		44206
1000024	3	2	discussion of overall management	44206
1000024	1	1		45035
1000024	3	1	page 13 discusses ACEi, ARB, aldosterone antagonist after stabilization	45035
1000024	1	2.5		44686
1000024	3	1	page 12 - do not routinely offer, although clearly indicated if "potentially reversible cardiogenic shock"	44686
1000024	1	1		44340
1000024	3	1	page 13 - if stable, continue beta blockers or start them during admission	44340
1000024	1	1		44309
1000024	3	1	page 11	44309
1000024	1	1		44357
1000024	3	1	page 13 discusses ACEi, ARB, aldosterone antagonist after stabilization	44357
1000024	1	3		44428
1000024	3	2	page 11 - avoid narcotics, there are other medications that should be avoided too	44428
1000024	1	2.1		44389
1000024	3	2	discussion of overall management	44389
1000024	1	2.5		44319
1000024	3	1	page 11	44319
1000024	1	2.5		44393
1000024	3	2	page 13, discusses beta blockers, calcium chanell blockers not indicated in most instances	44393
1000024	1	3		44301
1000024	3	2	page 11 - avoid narcotics, there are other medications that should be avoided too	44301
1000024	1	2.5		44251
1000024	3	1	page 12 - do not routinely offer, although clearly indicated if "potentially reversible cardiogenic shock"	44251
1000024	1	2.5		44323
1000024	3	1	page 12 - do not routinely offer, although clearly indicated if "potentially reversible cardiogenic shock"	44323
1000024	1	1		45190
1000024	3	1	page 13 discusses ACEi, ARB, aldosterone antagonist after stabilization	45190
1000024	1	2.5		44297
1000024	3	1	page 11	44297
1000024	1	1		44004
1000024	3	1	page 11	44004
1000024	1	2.5		44241
1000024	1	2.5		44256
1000024	1	2.5		44285
1000024	3	1	page 12 (do not routinely offer)	44241
1000024	3	1	page 12	44256
1000024	3	1	page 12	44285
1000024	1	1		44374
1000024	3	1	page 13 discusses ACEi, ARB, aldosterone antagonist after stabilization	44374
1000024	1	1		44222
1000024	3	2	intro - likely admission	44222
1000024	1	2.5		45427
1000024	3	1	page 12 - do not routinely offer, although clearly indicated if "potentially reversible cardiogenic shock"	45427
1000024	1	2.1		44412
1000024	3	2	pharmacologic therapy - > i.e., if need afterload reduction but ACE or ARB contraindicated due to AKI	44412
1000024	1	3		44271
1000024	3	2	page 11 - avoid narcotics, there are other medications that should be avoided too	44271
1000024	1	2.1		44242
1000024	3	2	pharmacologic therapy - > i.e., if need afterload reduction but ACE or ARB contraindicated due to AKI	44242
1000024	1	2.1		44367
1000024	3	2	pharmacologic therapy - > i.e., if need afterload reduction but ACE or ARB contraindicated due to AKI	44367
1000024	1	1		44250
1000024	3	2	intro - likely admission	44250
1000024	1	1		44005
1000024	3	1	page 13 - if stable, continue beta blockers or start them during admission	44005
1000024	1	1		44347
1000024	3	1	page 13 discusses ACEi, ARB, aldosterone antagonist after stabilization	44347
1000024	1	2.5		44294
1000024	3	1	page 11	44294
1000024	1	3		44341
1000024	3	2	page 11 - avoid narcotics, there are other medications that should be avoided too	44341
1000024	1	3		35133
1000024	3	3	page 12	35133
1000024	1	2.5		44023
1000024	3	1	page 11	44023
1000024	1	3		44198
1000024	3	2	discussion of diuresis in intro	44198
1000024	1	1		44430
1000024	3	1	page 13 discusses ACEi, ARB, aldosterone antagonist after stabilization	44430
1000022	1	1		49207
1000022	3	2	page 1-3, some patients may require admission	49207
1000022	1	1		45818
1000022	3	1	page 1 for hospitalized patients	45818
1000022	1	1		45801
1000022	3	1	page 1 for hospitalized patients	45801
1000022	1	2.1		49054
1000022	3	2	page 3 discussing respiratory DFA	49054
1000022	1	1		45760
1000022	3	1	page 1 point 9	45760
1000022	1	2.1		45752
1000022	3	1	page 2, grade D	45752
1000022	1	2.1		45901
1000022	3	1	page 2, grade D	45901
1000022	1	2		45788
1000022	3	1	page 1 full blood count, although interestingly B minus for this and B+ for CRP?)	45788
1000022	1	3	should get full blood count instead, which includes diff	45793
1000022	3	1	page 1 full blood count, although interestingly B minus for this and B+ for CRP?)	45793
1000022	1	2.5		45978
1000022	3	2	page 4 steroids not routinely recommended (presumably either for anti-inflam effect or empiric stress dosing)	45978
1000022	1	1		46044
1000022	3	1	page 1	46044
1000022	1	2.1		62023
1000022	3	1	page 3	62023
1000022	1	2		46006
1000022	3	1	page 2 grade B-	46006
1000022	1	2.1		45910
1000022	3	1	page 1 grade D	45910
1000022	1	2.1		49478
1000022	3	1	page 2 D	49478
1000022	1	1		45835
1000022	3	1	page 2 B+ 	45835
1000022	1	1		45763
1000022	3	1	page 2 B+ for basic lytes, D for LFTs	45763
1000022	1	2		45771
1000022	3	1	page 2 B+ for basic lytes, D for LFTs	45771
1000022	1	1		45806
1000022	3	1	page 2 B+ for basic lytes, D for LFTs	45806
1000022	1	2.5		45853
1000022	3	2	page 13 PNA epidemiology differs in HF patients	45853
1000022	1	2.1		50253
1000022	3	2		50253
1000022	1	2.1		46020
1000022	3	2	as part of risk stratification suggested in intro	46020
1000022	1	2.1		45838
1000022	3	2	as part of risk stratification suggested in intro	45838
1000022	1	2.1		45759
1000022	3	2	could be considered part of LFTs mentioned on page 1	45759
1000022	1	2.1		45770
1000022	3	2	could be considered part of LFTs mentioned on page 1	45770
1000022	1	2.5	if do culture, do gram stain	46179
1000022	3	1	page 2 culture A-	46179
1000022	1	1		48544
1000022	3	1	page 2 culture A-	48544
1000022	1	2.1		45792
1000022	3	2	page 1 "microbiologic tests" extend guided by severity	45792
1000022	1	2.5		45879
1000022	3	2	discussing of severity, page 26, some empyemas need drainage or VATS	45879
1000022	1	2.5		45972
1000022	3	2	page 6 discussion of staph aureus PNA	45972
1000022	1	2.5		44208
1000022	3	2	page 13 discusses COPD	44208
1000022	1	2.5		44349
1000022	3	2	page 13 discusses COPD	44349
1000022	1	2.5		44252
1000022	3	2	page 5 avoid inappropriate abx	44252
1000022	1	2.5		44237
1000022	3	2	page 5 avoid inappropriate abx	44237
1000022	1	2.5		44391
1000022	3	2	page 5 avoid inappropriate abx	44391
1000022	1	1		45787
1000022	3	1	page 3 A = rec re: mobility	45787
1000022	1	1		45854
1000022	3	1	page 3 A = rec re: mobility	45854
1000022	1	2.1		45955
1000022	3	2	as part of risk stratification suggested in intro	45955
1000022	1	1		46185
1000022	3	1	page 1 point 9	46185
1000022	1	2.1		45914
1000022	3	2	as part of risk stratification suggested in intro	45914
1000022	1	1		45776
1000022	3	1	page 3 A = rec re: mobility	45776
1000022	1	1		45758
1000022	3	1	page 3 A = rec re: mobility	45758
1000022	1	2.5		50116
1000022	3	2	page 3 = airway clearance techniques discussed, grade D, but not routine	50116
1000022	1	2.5		49144
1000022	3	2	page 3 = airway clearance techniques discussed, grade D	49144
1000022	1	2.5		45830
1000022	3	2	page 3 = airway clearance techniques discussed, grade D	45830
1000022	1	2.5		46030
1000022	3	1	page 4 -> not routinely indicated	46030
1000022	1	1		46336
1000022	3	1	page 2 culture A-	46336
1000022	1	2.1		45921
1000022	3	1	page 3	45921
1000022	1	2.5		43997
1000022	3	2	page 5 - avoid inappropriate antibiotic prescribing, page 6 PVL-SA recommend linezolid, but staph aureus less usual	43997
1000022	1	2.5		44678
1000022	3	2	page 5 - avoid inappropriate antibiotic prescribing 	44678
1000022	1	2	page 9 limit use of respiratory fluoroquinolones	46445
1000022	1	2	page 9 limit use of respiratory fluoroquinolones	46335
1000022	3	2	page 4 levofloxacin monotherapy one option	46445
1000022	3	2	page 4 levofloxacin monotherapy one option	46335
1000022	1	2.1		35849
1000022	1	2.1		44388
1000022	3	1	page 4	35849
1000022	3	1	page 4	44388
1000022	1	2.5		36210
1000022	3	2	page 5 - avoid inappropriate antibiotic prescribing, page 6 discusses unusual pathogens	36210
1000022	1	2.5		44255
1000022	3	2	page 4 low risk PNA	44255
1000022	1	2.5		45060
1000022	1	2		35733
1000022	3	2	page 4, 5 as part of combination therapy	45060
1000022	3	1	page 4, 5 as part of combination therapy	35733
1000022	1	2.5		44262
1000022	3	2	page 9, cipro not a respiratory fluoroquinolone	44262
1000022	1	2.1		45480
1000022	3	2	discusses respiratory viral panel	45480
1000022	1	3		44008
1000022	3	2	page 5 - avoid inappropriate antibiotic prescribing 	44008
1000022	1	2.5		43998
1000022	3	2	page 5 - avoid inappropriate antibiotic prescribing 	43998
1000022	1	2.5		44319
1000022	3	2	discussion of treating pleuritic pain in outpatients with tylenol	44319
1000022	1	2.1		46261
1000022	1	2.1		44626
1000022	3	1	page 4 	46261
1000022	3	1	page 4 	44626
1000022	1	2.1		44222
1000022	3	2	page 1-3, discussing admission	44222
1000022	1	2.5		44230
1000022	3	1	page 4 steroids not routine	44230
1000022	1	2.1		44250
1000022	3	2	page 1-3, discussing admission	44250
1000022	1	2.5		45225
1000022	3	1	page 4 A+ recommendation, not routinely recommended	45225
1000022	1	2		46468
1000022	3	1	page 4, "low severity CAP"	46468
1000022	1	2	page 9 limit use of respiratory fluoroquinolones	44324
1000022	1	2	page 9 limit use of respiratory fluoroquinolones	44299
1000022	3	1	page 4 levofloxacin monotherapy one option	44324
1000022	3	1	page 4 levofloxacin monotherapy one option	44299
1000022	1	2		44198
1000022	3	1	page 3 grade C	44198
1000023	1	1		49207
1000023	3	2	S28 hospital admission decision	49207
1000023	1	2.5		45784
1000023	3	2		45784
1000023	1	2.5		45811
1000023	3	2		45811
1000023	1	2.1		45866
1000023	3	2	S28 risk stratificaiton	45866
1000023	1	2		45818
1000023	3	1	S28	45818
1000023	1	2		45801
1000023	3	1	S28	45801
1000023	1	2.1		49054
1000023	3	2	S43 discussing influenza, etc.	49054
1000023	1	2.1		45760
1000023	3	2	S28 discussing specific PaO2/FiO2 criteria for ICU admission	45760
1000023	1	2		45752
1000023	3	1	S17 - may be optional in low risk patients but indicated in high risk patients	45752
1000023	1	2		45901
1000023	3	1	S17 - may be optional in low risk patients but indicated in high risk patients	45901
1000023	1	1		45788
1000023	3	2	S28 discussing leuklpenia, thrombocytopenia, labs for risk stratification	45788
1000023	1	2.5		45793
1000023	3	2	S28 discussing leuklpenia, thrombocytopenia, labs for risk stratification	45793
1000023	1	2.5		45978
1000023	3	1	S56 screen hypotensive fluid resuscitation patients with severe CAP, presumably not large subset of patients	45978
1000023	1	2.1		46044
1000023	3	2	intro re: risk stratification	46044
1000023	1	1		62023
1000023	3	1	S43, especially helpful for influenza	62023
1000023	1	2.5	do gram stain and culture as well rather than just gram stain	46006
1000023	3	1	S29, S42	46006
1000023	1	2.1		45910
1000023	3	2	S28, legionella discussed, may want LFTs too	45910
1000023	1	2.5		49478
1000023	3	2	S29, antigen seems preferred	49478
1000023	1	2		45835
1000023	3	1	S29	45835
1000023	1	2.1		45763
1000023	3	2	S28 risk stratification	45763
1000023	1	2.1		45771
1000023	3	2	S28, legionella discussed, may want LFTs too	45771
1000023	1	2.1		45806
1000023	3	2	S28 risk stratification	45806
1000023	1	2.5		45853
1000023	3	2	initial triage	45853
1000023	1	2.1		50253
1000023	3	2	S28 risk stratification	50253
1000023	1	2.1		46020
1000023	3	2	S28 risk stratification	46020
1000023	1	2.1		45838
1000023	3	2	S28 risk stratification	45838
1000023	1	2.1		45759
1000023	3	2	S28 risk stratification including hepatic dysfunction if legionella	45759
1000023	1	2.1		45770
1000023	3	2	S28 risk stratification including hepatic dysfunction if legionella	45770
1000023	1	2.5	do gram stain as well	46179
1000023	3	1	S29, S42	46179
1000023	1	2		48544
1000023	3	1	S29, S42	48544
1000023	1	2.1		45792
1000023	3	2	discussion of CA MRSA S 47	45792
1000023	1	2.5		45879
1000023	3	2	implied during discussion of non-resolving PNA (?source control procedures)	45879
1000023	1	2.5	CA-MRSA CAP "reamins rare"	45972
1000023	3	1	S50, S47	45972
1000023	1	2.5		44208
1000023	3	2	COPD mentioned, i.e, Table 12, but these are not part of standard therapy	44208
1000023	1	2.5		44349
1000023	3	2	COPD mentioned, i.e, Table 12, but these are not part of standard therapy	44349
1000023	1	2.5		44252
1000023	3	2	Table 9 if pseudomonas or aspiration, but not part of empiric regimen for non ICU or ICU 	44252
1000023	1	2.5		44237
1000023	3	2	Table 9 if pseudomonas or aspiration, but not part of empiric regimen for non ICU or ICU 	44237
1000023	1	2.5		44391
1000023	3	2	Table 9 if pseudomonas or aspiration, but not part of empiric regimen for non ICU or ICU 	44391
1000023	1	1		45787
1000023	3	2		45787
1000023	1	1		45854
1000023	3	2		45854
1000023	1	2.1		45955
1000023	3	2	S28 risk stratification	45955
1000023	1	2.1		46185
1000023	3	2	S28 risk stratification	46185
1000023	1	2.1		45914
1000023	3	2	S28 risk stratification	45914
1000023	1	1		45776
1000023	3	2		45776
1000023	1	1		45758
1000023	3	2		45758
1000023	1	2.5		50116
1000023	3	2	as part of overall care	50116
1000023	1	2.5		49144
1000023	3	2	as part of overall care	49144
1000023	1	2.5		45830
1000023	3	2	as part of overall care	45830
1000023	1	2.5		46030
1000023	3	2	S28 triage to ICU	46030
1000023	1	2		46336
1000023	3	2	S29 need a good sample	46336
1000023	1	1		45921
1000023	3	2	S28	45921
1000023	1	2.5	CA-MRSA CAP "reamins rare"	43997
1000023	3	1	S50, S47	43997
1000023	1	2.5		44678
1000023	3	2	Table 9, could be reasonable choice if PCN allergy, but not first - line	44678
1000023	1	1		46445
1000023	1	1		46335
1000023	3	1		46445
1000023	3	1	Table 9 defined as respiratory fluoroquinolone	46335
1000023	1	1		35849
1000023	1	1		44388
1000023	3	1	S48, S49 regarding standard regimens for non-ICU and ICU treatment	35849
1000023	3	1	S48, S49 regarding standard regimens for non-ICU and ICU treatment	44388
1000023	1	2.5		36210
1000023	3	2	S49 discussing pseudomonas, but this is not typical case	36210
1000023	1	2.5		44255
1000023	3	2	Table 9 not a first choice	44255
1000023	1	2.5	IM generally not preferred	45060
1000023	1	1		35733
1000023	3	1	S48, S49 regarding standard regimens for non-ICU and ICU treatment	45060
1000023	3	1	S48, S49 regarding standard regimens for non-ICU and ICU treatment	35733
1000023	1	2.5		44262
1000023	3	1	Table 9 for double coverage of pseudomonas, not standard	44262
1000023	1	1		45480
1000023	3	1	Table 9	45480
1000023	1	2.5		44008
1000023	3	2	Table 9 re: aspiration, alternative agent = carbapenem	44008
1000023	1	2.1		43998
1000023	3	1	S48 ertapenem for selected patients	43998
1000023	1	2.5		44319
1000023	3	2	intro re: admission	44319
1000023	1	2.5		46261
1000023	1	2.5		44626
1000023	3	1	S48 doxy as alternative to macrolide, level III evidence	46261
1000023	3	1	S48 doxy as alternative to macrolide, level III evidence	44626
1000023	1	2.1		44222
1000023	3	2	intro decision to admit	44222
1000023	1	2.5		44230
1000023	3	1	S56 in subset of patients may be indicated	44230
1000023	1	2.1		44250
1000023	3	2	intro decision to admit	44250
1000023	1	2.5		46468
1000023	3	1	Table 9, for H influenza some strains, but not listed as part of standard therapy	46468
1000023	1	1		44324
1000023	1	1		44299
1000023	3	1	S48, S49 regarding standard regimens for non-ICU and ICU treatment	44324
1000023	3	1	S48, S49 regarding standard regimens for non-ICU and ICU treatment	44299
1000023	1	1		44198
1000023	3	2	S28 discussion of septic shock and hypotension requiring aggressive fluid resuscitation	44198
1000014	1	2.5		63811
1000014	3	2	page 2642	63811
1000014	1	2.1		62215
1000014	3	2	syncope -> trauma	62215
1000014	1	1		49251
1000014	3	2	page 2656	49251
1000014	1	2		49207
1000014	3	2	page 2665	49207
1000014	1	1		50202
1000014	3	1	page 2656	50202
1000014	1	1		49678
1000014	3	1	page 2654	49678
1000014	1	1		61832
1000014	3	1	page 2653	61832
1000014	1	1		62176
1000014	3	1	page 2653	62176
1000014	1	1		52590
1000014	3	1	page 2653	52590
1000014	1	2		62057
1000014	3	1	page 2649	62057
1000014	1	1		45866
1000014	3	1	page 2644	45866
1000014	1	2.5		45983
1000014	3	1	page 2656	45983
1000014	1	2.5		48524
1000014	3	2	page 2656	48524
1000014	1	2.5		48676
1000014	3	2	page 2642	48676
1000014	1	2.5		45762
1000014	3	2	page 2642	45762
1000014	1	2.5		50989
1000014	3	2	page 2642	50989
1000014	1	2.5		46039
1000014	3	1	page 2656	46039
1000014	1	2.5		46065
1000014	3	1	page 2656	46065
1000014	1	3		48773
1000014	3	1	page 2656	48773
1000014	1	2.5		45823
1000014	3	2	page 2642 implied	45823
1000014	1	2.5		45788
1000014	3	2	page 2644 ("blood tests")	45788
1000014	1	2.1		45793
1000014	3	2	page 2644 ("blood tests")	45793
1000014	1	2.1		48532
1000014	3	2	page 2644 ("blood tests")	48532
1000014	1	2.1		45763
1000014	3	2	page 2644 ("blood tests")	45763
1000014	1	2.1		45771
1000014	3	2	page 2644 ("blood tests")	45771
1000014	1	2.1		45806
1000014	3	2	page 2644 ("blood tests")	45806
1000014	1	2.5		45853
1000014	3	2	page 2644 ("blood tests")	45853
1000014	1	2.5		46020
1000014	3	2	page 2644 ("blood tests")	46020
1000014	1	2.1		65655
1000014	3	2	page 2644 ("blood tests")	65655
1000014	1	2.1		46098
1000014	3	2	page 2644 ("blood tests")	46098
1000014	1	2.5		45942
1000014	3	2	page 2644 ("blood tests")	45942
1000014	1	1		45838
1000014	3	2	page 2653	45838
1000014	1	2.5		45759
1000014	3	2	page 2644 ("blood tests")	45759
1000014	1	2.5		45770
1000014	3	2	page 2644 ("blood tests")	45770
1000014	1	2.5		45879
1000014	3	1	p 2649, 2660 (implantable loop recorders, ICDs, etc.)	45879
1000014	1	1		45870
1000014	3	2	page 2653	45870
1000014	1	2.5		45945
1000014	3	2	page 2642, other causes of syncope	45945
1000014	1	2.5		46200
1000014	3	1	page 2656	46200
1000014	1	1		45787
1000014	3	2	page 2662	45787
1000014	1	1		45854
1000014	3	2	page 2662	45854
1000014	1	1		45914
1000014	3	2	page 2653	45914
1000014	1	1		45841
1000014	3	2	page 2662	45841
1000014	1	1		45776
1000014	3	2	page 2662	45776
1000014	1	1		45758
1000014	3	2	page 2662	45758
1000014	1	3		46605
1000014	3	1	page 2652	46605
1000014	1	2.1		44319
1000014	3	2	implied if trauma	44319
1000014	1	2.5		46462
1000014	3	1	page 2659	46462
1000014	1	2.1		44222
1000014	3	2	page 2665 if admit	44222
1000014	1	3		44005
1000014	3	1	page 2657, 2658	44005
1000014	1	2.5		44756
1000014	3	1	page 2659	44756
1000014	1	1		44198
1000014	3	2	page 2639 orthostatic hypotension	44198
1000014	1	3		62214
1000014	3	2	page 2656	62214
1000015	1	2.5		63811
1000015	3	1	page 9, uncommon, if SAH concern would image first	63811
1000015	1	2.1		62215
1000015	3	2	page 5, trauma	62215
1000015	1	1		49251
1000015	3	2	page 2	49251
1000015	1	2		49207
1000015	3	2	page 11, 13, deciding whether to admit or not	49207
1000015	1	1		50202
1000015	3	2	page 1, 2	50202
1000015	1	1		49678
1000015	3	2	page 3	49678
1000015	1	1		61832
1000015	3	1	page 8	61832
1000015	1	1		62176
1000015	3	1	page 8	62176
1000015	1	1		52590
1000015	3	2	page 2	52590
1000015	1	1		62057
1000015	3	1	page 7	62057
1000015	1	1		45866
1000015	3	1	page 7, one thing everyone should get	45866
1000015	1	2.1		45983
1000015	3	1	page 8	45983
1000015	1	2.1		48524
1000015	3	2	page 8, page 5 (trauma)	48524
1000015	1	2.1		48676
1000015	3	1	page 9	48676
1000015	1	2.1		45762
1000015	3	2	page 9	45762
1000015	1	2.1		50989
1000015	3	2	page 9	50989
1000015	1	1		46039
1000015	3	1	page 8	46039
1000015	1	2.1		46065
1000015	3	1	page 8 	46065
1000015	1	3		48773
1000015	3	2	page 8	48773
1000015	1	2.5		45823
1000015	3	2	page 8, if hemorrhage, gotta do it	45823
1000015	1	2.5		45788
1000015	3	1	page 7	45788
1000015	1	2.1		45793
1000015	3	1	page 7	45793
1000015	1	2.1		48532
1000015	3	2	page 9	48532
1000015	1	2.1		45763
1000015	3	1	page 7	45763
1000015	1	2.5		45771
1000015	3	1	page 7	45771
1000015	1	2.1		45806
1000015	3	1	page 7	45806
1000015	1	2.5		45853
1000015	3	1	page 8	45853
1000015	1	2.5		46020
1000015	3	2	page 7	46020
1000015	1	2.1		65655
1000015	3	1	page 7	65655
1000015	1	2.1		46098
1000015	3	1	page 7	46098
1000015	1	2.5		45942
1000015	3	2	page 7	45942
1000015	1	2.5		45838
1000015	3	1	page 8	45838
1000015	1	2.5		45759
1000015	3	2	page 7	45759
1000015	1	2.5		45770
1000015	3	2	page 7	45770
1000015	1	2.5		45870
1000015	3	1	page 8	45870
1000015	1	1		45945
1000015	3	2	page 8/9	45945
1000015	1	1		46200
1000015	3	1	page 9	46200
1000015	1	1		45787
1000015	3	2	page 4/5, frail elderly, trauma, etc.	45787
1000015	1	1		45854
1000015	3	2	page 4/5, frail elderly, trauma, etc.	45854
1000015	1	2.5		45914
1000015	3	1	page 8	45914
1000015	1	2.1		48561
1000015	3	1	page 7	48561
1000015	1	1		45841
1000015	3	2	page 4/5, frail elderly, trauma, etc.	45841
1000015	1	1		45776
1000015	3	2	page 4/5, frail elderly, trauma, etc.	45776
1000015	1	1		45758
1000015	3	2	page 4/5, frail elderly, trauma, etc.	45758
1000015	1	2.1		44319
1000015	3	2	page 5, if associated trauma	44319
1000015	1	2.1		44222
1000015	3	2	page 13, if considering admission	44222
1000015	1	2.1		44198
1000015	3	2	page 2, if orthostatic	44198
1000015	1	3		62214
1000015	3	2	page 8	62214